{"meta":{"query_hash":"d3462be9f624","filters":{"venue":"Expert Review of Clinical Pharmacology"},"cohort_total":70,"direct_labels_cover":2,"predictions_cover":70,"exported":70,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d3462be9f624","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Review+of+Clinical+Pharmacology"},"results":[{"id":"W1974375960","doi":"10.1586/17512433.2013.811831","title":"Gram-negative superbugs: inappropriate antimicrobial therapy and mortality","year":2013,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Medicine; Antimicrobial; Intensive care medicine; Drug resistance; Antibiotic resistance; Antimicrobial drug; Pharmacotherapy; Anti-Infective Agents; Immunology; Antibiotics; Microbiology; Internal medicine; Biology","score_opus":0.04156694133645708,"score_gpt":0.4392310278738546,"score_spread":0.3976640865373975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974375960","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005290627,0.03519744,0.00015164574,0.07165163,0.89172524,0.000015517686,0.000053128184,0.000053473792,0.0010991244],"genre_scores_gemma":[0.00057092984,0.029081423,0.00014759129,0.04634688,0.91897964,0.000021077567,0.000040191673,0.00003217822,0.0047800317],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969035,0.0007372654,0.0005056989,0.000291186,0.0013772533,0.00018519469],"domain_scores_gemma":[0.98405683,0.0078114206,0.00096587813,0.00024513088,0.005669093,0.001251645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056018867,0.0024235821,0.002621238,0.0018255997,0.0015743049,0.003752136,0.0029351555,0.011774741,0.0068595503],"category_scores_gemma":[0.020193456,0.0009165114,0.0017710289,0.0010965901,0.0020524217,0.0028492769,0.0011861658,0.018761171,0.0065200464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002742148,0.000005770769,0.000023894298,0.00022594133,0.00001882759,0.00007880048,0.000008662389,0.000015921452,0.000028295895,0.00021055568,0.99184036,0.0075156325],"study_design_scores_gemma":[0.00011157506,0.00005210272,0.0005659002,0.0016976995,0.0001414672,0.00070198614,0.00005148156,0.00019149367,0.0001510826,0.0013650984,0.9949373,0.00003286469],"about_ca_topic_score_codex":0.0024191088,"about_ca_topic_score_gemma":0.006176861,"teacher_disagreement_score":0.011774741,"about_ca_system_score_codex":0.002667845,"about_ca_system_score_gemma":0.002645139,"threshold_uncertainty_score":0.029625952},"labels":[],"label_agreement":null},{"id":"W1983885439","doi":"10.1586/ecp.10.49","title":"Advances in oral anticoagulants: focus on dabigatran etexilate","year":2010,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabigatran; Medicine; Intensive care medicine; Rivaroxaban; Pharmacology; Atrial fibrillation; Warfarin; Internal medicine","score_opus":0.13370751864452812,"score_gpt":0.5562791191571606,"score_spread":0.42257160051263243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983885439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003366439,0.98322314,0.00058305025,0.011705887,0.0008849361,0.000007212849,0.000011267982,0.000013212118,0.0032346258],"genre_scores_gemma":[0.0023724367,0.9856542,0.0014770188,0.0053881155,0.0034464526,0.0000085075835,0.000016404974,0.000007991144,0.00162885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860966,0.00040969017,0.00021487818,0.00019261664,0.00049270183,0.00008040422],"domain_scores_gemma":[0.9950611,0.0026405468,0.00032388698,0.00012755237,0.0015130934,0.00033379495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041526374,0.0007604242,0.0016432123,0.0018927428,0.00035457138,0.002298849,0.000715075,0.0025460871,0.0055816746],"category_scores_gemma":[0.0035723806,0.00027549572,0.0006825419,0.0020696397,0.0013045607,0.0038324962,0.001213307,0.0037071542,0.0026051248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002190535,0.00030566237,0.00069786626,0.0052580317,0.00007970699,0.00030088625,0.00013267211,0.00031823423,0.002171055,0.018774731,0.04627584,0.9254662],"study_design_scores_gemma":[0.000110510984,0.00033781448,0.0014486925,0.0031643831,0.00008412831,0.001482787,0.0001299758,0.00022446885,0.0007286262,0.007890547,0.9843658,0.000032167067],"about_ca_topic_score_codex":0.0014953654,"about_ca_topic_score_gemma":0.0029649101,"teacher_disagreement_score":0.0055816746,"about_ca_system_score_codex":0.0012682067,"about_ca_system_score_gemma":0.002006989,"threshold_uncertainty_score":0.02196151},"labels":[],"label_agreement":null},{"id":"W1989316273","doi":"10.1586/ecp.12.72","title":"Current issues in biowaivers and biosimilars","year":2013,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Protein purification and stability","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biosimilar; Medicine; Library science; Family medicine; Internal medicine","score_opus":0.04851537287578259,"score_gpt":0.48056864695647394,"score_spread":0.43205327408069133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989316273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006282018,0.8055794,0.001108098,0.16864696,0.012343943,0.000021281108,0.00009213508,0.000044066936,0.011535859],"genre_scores_gemma":[0.013227288,0.84530735,0.0025152778,0.09266732,0.03724038,0.00007541699,0.00021562343,0.000062825144,0.008688552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9870816,0.0031970355,0.0024994733,0.0012976938,0.0051440536,0.0007801382],"domain_scores_gemma":[0.9688477,0.016233005,0.0038308855,0.0007318533,0.0083307475,0.0020258299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026635848,0.00085246185,0.0019316586,0.002175467,0.0016341965,0.0090620825,0.0029601397,0.0128195,0.014540464],"category_scores_gemma":[0.02726025,0.00072769215,0.001101812,0.0039422223,0.005570099,0.013110643,0.0026240742,0.010784196,0.0053966423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002623828,0.00019385605,0.0005067429,0.005429123,0.00006119669,0.0004508898,0.00040367333,0.00038146318,0.0012160188,0.082727656,0.24975151,0.6586155],"study_design_scores_gemma":[0.000020812728,0.000070915245,0.00032081595,0.0020218072,0.000024639028,0.00055994245,0.00029298454,0.00006359051,0.00030141926,0.015218883,0.9810863,0.000017838556],"about_ca_topic_score_codex":0.0024052374,"about_ca_topic_score_gemma":0.0027953798,"teacher_disagreement_score":0.026635848,"about_ca_system_score_codex":0.0052712755,"about_ca_system_score_gemma":0.008839501,"threshold_uncertainty_score":0.14086545},"labels":[],"label_agreement":null},{"id":"W1994783490","doi":"10.1586/ecp.09.37","title":"Transdermal contraceptive patches: current status and future potential","year":2009,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transdermal patch; Pill; Bust; Transdermal; Dosing; Venous thromboembolism; Boom; Pharmacology; Surgery; Thrombosis","score_opus":0.04731593212537507,"score_gpt":0.49519299677766454,"score_spread":0.4478770646522895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994783490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091730856,0.9827626,0.00035136993,0.011909227,0.0003471009,0.000010877996,0.000028633473,0.000030041927,0.0036427723],"genre_scores_gemma":[0.0074316286,0.98359907,0.0012177494,0.003895531,0.0015560702,0.000029996638,0.000068499285,0.000009288184,0.002192108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900585,0.00026165028,0.00014716493,0.00014779335,0.00033117828,0.00010639351],"domain_scores_gemma":[0.99495333,0.00269895,0.0007630735,0.000085014755,0.00096176134,0.000537804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005503276,0.0006491907,0.0013524315,0.0013490526,0.00047957033,0.002938712,0.0014016551,0.0046209786,0.012357457],"category_scores_gemma":[0.0038069237,0.00037895804,0.0007577882,0.0017004958,0.0017507527,0.006039462,0.0007618422,0.0032792715,0.0033558046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002938552,0.00027056393,0.0010097675,0.0045533567,0.000034800105,0.00031249356,0.00015529609,0.00019805794,0.0010003865,0.0049110944,0.020475147,0.966785],"study_design_scores_gemma":[0.00014078915,0.0013975329,0.0032879114,0.0065666107,0.00013876328,0.003281668,0.0008979105,0.00057172833,0.0009102331,0.008748645,0.9739885,0.00006981496],"about_ca_topic_score_codex":0.0008962764,"about_ca_topic_score_gemma":0.0031762363,"teacher_disagreement_score":0.012357457,"about_ca_system_score_codex":0.0010213475,"about_ca_system_score_gemma":0.0021757558,"threshold_uncertainty_score":0.041339755},"labels":[],"label_agreement":null},{"id":"W1994861629","doi":"10.1586/ecp.09.62","title":"Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies","year":2010,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Endocannabinoid system; Synthetic cannabinoids; Medicine; Cannabinoid receptor; Cannabis sativa; Pharmacology; Cannabinoid; Effects of cannabis; Neuroscience; Bioinformatics; Cannabis; Cannabidiol; Biology; Receptor; Internal medicine; Psychiatry","score_opus":0.036792649526553964,"score_gpt":0.46066594782908776,"score_spread":0.4238732983025338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994861629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065957806,0.95472467,0.0069393795,0.01842261,0.0007038073,0.00013242148,0.00007447168,0.00015350939,0.012253353],"genre_scores_gemma":[0.038709633,0.93158466,0.014203268,0.0049332613,0.0024343356,0.0002767706,0.00013513971,0.000022827586,0.0077001387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986887,0.000039419338,0.000011637941,0.0000182479,0.00003551456,0.000026208378],"domain_scores_gemma":[0.99981457,0.00007036599,0.000023873747,0.000009104442,0.00003908994,0.000043005173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007153855,0.00072984165,0.001054258,0.0009260199,0.0004079597,0.0010525319,0.0009540607,0.0019427014,0.011721075],"category_scores_gemma":[0.00037249082,0.00018866861,0.0005821033,0.00040019501,0.0008008639,0.0013452887,0.0007267413,0.002122649,0.00243386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085238734,0.0010521745,0.00077727495,0.005317617,0.00011758151,0.0015023608,0.00018145035,0.00066206366,0.027493048,0.011401749,0.01833867,0.9323036],"study_design_scores_gemma":[0.0017841433,0.0047993176,0.007227573,0.00467168,0.00070428464,0.01194913,0.0011537347,0.0023386492,0.017062234,0.043455623,0.9046909,0.00016258114],"about_ca_topic_score_codex":0.0005800049,"about_ca_topic_score_gemma":0.0018992408,"teacher_disagreement_score":0.011721075,"about_ca_system_score_codex":0.00057148014,"about_ca_system_score_gemma":0.0011037367,"threshold_uncertainty_score":0.039210916},"labels":[],"label_agreement":null},{"id":"W2005759075","doi":"10.1586/17512433.2013.842465","title":"Optimizing glycemic control: lixisenatide and basal insulin in combination therapy for the treatment of Type 2 diabetes mellitus","year":2013,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Medicine; Glycemic; Lixisenatide; Postprandial; Internal medicine; Hypoglycemia; Type 2 Diabetes Mellitus; Endocrinology; Basal (medicine); Diabetes mellitus; Insulin; Type 2 diabetes; Basal insulin","score_opus":0.0986510902370301,"score_gpt":0.47317738335092646,"score_spread":0.37452629311389635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005759075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019065963,0.9983885,0.00015404892,0.00023561786,0.00015258022,0.00000882083,0.000012803865,0.0000065503036,0.000850382],"genre_scores_gemma":[0.0012304783,0.9973832,0.00034665718,0.00024789126,0.00018980923,0.000010761898,0.00002678855,0.0000019269683,0.00056249776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979657,0.00004319322,0.00002773323,0.000027255239,0.000089080924,0.000016200393],"domain_scores_gemma":[0.99986076,0.00005459397,0.000032891818,0.0000034591328,0.00003508743,0.000013275535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045977812,0.000743857,0.0013043717,0.0016552646,0.00018044871,0.0006467442,0.00070155336,0.00081108685,0.0040149316],"category_scores_gemma":[0.00039000317,0.00019842073,0.00055063993,0.0012666453,0.0002594715,0.0007655622,0.0005022223,0.0018344879,0.0018246147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015419628,0.00011961123,0.00009240424,0.014015345,0.00017486715,0.00015915155,0.000036531095,0.00026515964,0.0015768158,0.0013833354,0.017236572,0.96478593],"study_design_scores_gemma":[0.00022100493,0.00048455628,0.0016224018,0.010843179,0.00050208066,0.0028951871,0.000089855814,0.00039851136,0.0012385206,0.002788014,0.9788704,0.000046420322],"about_ca_topic_score_codex":0.00067174406,"about_ca_topic_score_gemma":0.0017217253,"teacher_disagreement_score":0.0040149316,"about_ca_system_score_codex":0.0003376194,"about_ca_system_score_gemma":0.0004190337,"threshold_uncertainty_score":0.013431311},"labels":[],"label_agreement":null},{"id":"W2015413562","doi":"10.1586/ecp.12.32","title":"Clinical pharmacology confounders in older adults","year":2012,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Confounding; Intensive care medicine; Disease; Psychological intervention; Clinical pharmacology; Drug; Quality of life (healthcare); Pharmacotherapy; Adverse effect; Population; Health care; Pharmacology; Internal medicine; Psychiatry; Environmental health","score_opus":0.6626429988281188,"score_gpt":0.6641739356241866,"score_spread":0.00153093679606775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015413562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022966335,0.99808574,0.00016663584,0.000669867,0.00006132512,0.000010085335,0.000029191458,0.00000203273,0.00074544747],"genre_scores_gemma":[0.0051963734,0.99383026,0.00026697054,0.00029040937,0.00017300104,0.00001965009,0.00003206827,9.0902256e-7,0.00019038902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860245,0.000732162,0.000207278,0.00009620321,0.0003267294,0.000035187477],"domain_scores_gemma":[0.9947237,0.0037653095,0.0010101439,0.000077704884,0.0003583555,0.000064812884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030844605,0.00058295333,0.0016868697,0.0020212326,0.00017113285,0.0014182526,0.0005544213,0.0011963602,0.004739776],"category_scores_gemma":[0.0090435045,0.00020591845,0.0010066335,0.0031701082,0.00048592986,0.00087704026,0.0006714243,0.0012394476,0.0004519564],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001722327,0.00012641402,0.0018053628,0.0504645,0.00073999085,0.00017324684,0.00006538707,0.0008227717,0.00016600778,0.014081812,0.015412787,0.9159695],"study_design_scores_gemma":[0.00031364345,0.00052088115,0.031597666,0.13688411,0.0036231617,0.0041875816,0.00039343734,0.001588681,0.0010184805,0.048207182,0.77155596,0.00010924767],"about_ca_topic_score_codex":0.0020986053,"about_ca_topic_score_gemma":0.0028088584,"teacher_disagreement_score":0.004739776,"about_ca_system_score_codex":0.0010662011,"about_ca_system_score_gemma":0.002726302,"threshold_uncertainty_score":0.01631242},"labels":[],"label_agreement":null},{"id":"W2021129775","doi":"10.1586/17512433.2.1.9","title":"Transitioning biomarkers into the clinic","year":2008,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical pharmacology; Editorial board; Medicine; Pharmacology; Library science","score_opus":0.10363176507144017,"score_gpt":0.5089950535381991,"score_spread":0.4053632884667589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021129775","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005755733,0.5653976,0.03461332,0.32486048,0.019991586,0.00023769574,0.00032501228,0.00065230235,0.04816616],"genre_scores_gemma":[0.118857615,0.5832962,0.06359281,0.15801448,0.046278033,0.00069260364,0.0006204794,0.00027335787,0.028374374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976422,0.0010220584,0.00020944416,0.0003121941,0.00061059446,0.00020347064],"domain_scores_gemma":[0.99365073,0.0023927188,0.00046161033,0.0004605495,0.002063581,0.0009708627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007491684,0.00065043796,0.0013517522,0.0023462465,0.00054074783,0.0062438827,0.0010077759,0.0027904608,0.008606657],"category_scores_gemma":[0.012784932,0.0003877383,0.00052843784,0.0014517391,0.002936282,0.009008838,0.0031022734,0.0071406728,0.0047233407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029867698,0.00026555784,0.003734479,0.0009534294,0.00006322186,0.0005372306,0.00035111385,0.00023920926,0.0035270245,0.05932083,0.12964725,0.80106205],"study_design_scores_gemma":[0.00013048155,0.0005752621,0.0017868311,0.0016187812,0.00005765558,0.0015118467,0.00056439056,0.000621853,0.0018471907,0.07176566,0.9194632,0.000056791436],"about_ca_topic_score_codex":0.0006498174,"about_ca_topic_score_gemma":0.0008221607,"teacher_disagreement_score":0.008606657,"about_ca_system_score_codex":0.0016422434,"about_ca_system_score_gemma":0.0026458711,"threshold_uncertainty_score":0.03962028},"labels":[],"label_agreement":null},{"id":"W2022186661","doi":"10.1586/17512433.2014.966812","title":"New treatments for the motor symptoms of Parkinson’s disease","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Levodopa; Medicine; Dyskinesia; Parkinson's disease; Dopaminergic; Clinical trial; Pharmacology; Dopamine; Disease; Internal medicine","score_opus":0.10460723580474432,"score_gpt":0.512091733561126,"score_spread":0.40748449775638174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022186661","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004353261,0.9678524,0.0018005655,0.0054330155,0.0031045156,0.00010646172,0.0003077295,0.00014026622,0.016901815],"genre_scores_gemma":[0.023872053,0.9316929,0.0057231816,0.0064997245,0.0038469713,0.00020223318,0.0009018532,0.00004021053,0.027220802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997702,0.00003338052,0.000027563168,0.000030486435,0.00011852132,0.000019881862],"domain_scores_gemma":[0.9998511,0.000036021076,0.00003098073,0.0000074225654,0.000049691116,0.000024739858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042571267,0.0004448313,0.00056915416,0.00081756694,0.0002595717,0.00047668332,0.000424565,0.0006958353,0.008477584],"category_scores_gemma":[0.00042138604,0.00010196463,0.0005959296,0.0003754574,0.0002694717,0.0008172971,0.00045281113,0.0017183224,0.0027382816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036298943,0.00029464107,0.00032124488,0.003829761,0.00008314253,0.00042850524,0.00008069423,0.00008438138,0.00706668,0.003175056,0.04909452,0.9351784],"study_design_scores_gemma":[0.00026111887,0.0007392002,0.002124437,0.0011876377,0.00013474026,0.002084187,0.000051715168,0.00011028056,0.0017550891,0.0018762219,0.9896562,0.000019289344],"about_ca_topic_score_codex":0.00042722173,"about_ca_topic_score_gemma":0.0017642564,"teacher_disagreement_score":0.008477584,"about_ca_system_score_codex":0.00031824005,"about_ca_system_score_gemma":0.00038024015,"threshold_uncertainty_score":0.028360367},"labels":[],"label_agreement":null},{"id":"W2022225262","doi":"10.1586/ecp.12.20","title":"Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis","year":2012,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Internal medicine; Esomeprazole; Community-acquired pneumonia; Lansoprazole; Proton-pump inhibitor; Pneumonia; Pantoprazole; Cohort study; MEDLINE; Odds ratio; Omeprazole; Incidence (geometry)","score_opus":0.3999750204036263,"score_gpt":0.5427896278345071,"score_spread":0.1428146074308808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022225262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048401173,0.9462921,0.0024409287,0.0005789956,0.00058338424,0.00032412398,0.0007384507,0.00008510777,0.0005557525],"genre_scores_gemma":[0.7548171,0.23699671,0.00387761,0.00096877775,0.00068966683,0.0008998873,0.0010776927,0.000064542844,0.00060802145],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9856091,0.009138371,0.0021222653,0.0016796652,0.00097057514,0.00047997214],"domain_scores_gemma":[0.9791869,0.015485147,0.0022385255,0.0014226432,0.0012059173,0.00046091748],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.019830631,0.003383288,0.014898082,0.005941514,0.0007661329,0.003713177,0.002740418,0.0031801003,0.0030203692],"category_scores_gemma":[0.028505957,0.0026084315,0.06706097,0.005790982,0.0005298104,0.0018336297,0.0015333965,0.0023776419,0.00036624967],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029429016,0.000022367518,0.011220361,0.013299841,0.96892494,0.000113500566,0.000023875042,0.00062261574,0.00011742632,0.000054678556,0.00021400234,0.002443544],"study_design_scores_gemma":[0.0006250529,0.00021774325,0.00672859,0.0012766044,0.9897342,0.00008787585,0.000022712205,0.00066842546,0.000074707685,0.00015195174,0.00039278012,0.000019343699],"about_ca_topic_score_codex":0.006890245,"about_ca_topic_score_gemma":0.009067557,"teacher_disagreement_score":0.9966167,"about_ca_system_score_codex":0.0018783076,"about_ca_system_score_gemma":0.0017383345,"threshold_uncertainty_score":0.104875624},"labels":[],"label_agreement":null},{"id":"W2057262282","doi":"10.1586/ecp.11.66","title":"Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response","year":2011,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Drug; Pharmacodynamics; Inflammation; Pharmacokinetics; Transporter; Pharmacology; Drug response; Drug development; Disease; Immunology; Bioinformatics; Biology; Internal medicine","score_opus":0.13661755918258842,"score_gpt":0.5009253919986094,"score_spread":0.36430783281602097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057262282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024170896,0.99774784,0.00026481625,0.0006378236,0.00009834985,0.000005132348,0.00002176748,0.000008273326,0.0009743133],"genre_scores_gemma":[0.0015041502,0.9972281,0.00033077155,0.00021713827,0.000101990525,0.0000080455975,0.000022263388,0.0000015009977,0.00058603607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979144,0.000053686366,0.000026612515,0.00003475683,0.000070317874,0.00002320627],"domain_scores_gemma":[0.99968576,0.00014147254,0.0000559416,0.000009869459,0.000083882005,0.000023076991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006164314,0.00059980707,0.0017538646,0.0012519557,0.00021465428,0.0011845343,0.00076451886,0.001236442,0.003693467],"category_scores_gemma":[0.00059517956,0.00023461269,0.000494558,0.0013866548,0.0005357476,0.0013146845,0.0005069707,0.0017007435,0.0023775753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001478071,0.00013953717,0.00038818255,0.015428676,0.00010616886,0.00052347675,0.0000925038,0.0007274755,0.008765061,0.007833587,0.02236308,0.9434844],"study_design_scores_gemma":[0.000049493807,0.00027144782,0.0020920795,0.003186419,0.00017477534,0.0035018965,0.00014599184,0.0004344211,0.0027199837,0.0058993013,0.98148155,0.00004258255],"about_ca_topic_score_codex":0.00065843255,"about_ca_topic_score_gemma":0.0014331896,"teacher_disagreement_score":0.003693467,"about_ca_system_score_codex":0.00073835434,"about_ca_system_score_gemma":0.0009769878,"threshold_uncertainty_score":0.012355864},"labels":[],"label_agreement":null},{"id":"W2070243746","doi":"10.1586/17512433.2013.811237","title":"Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease","year":2013,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Disease; Memantine; Clinical trial; Dementia; Intensive care medicine; Mechanism (biology); Drug development; Drug; Pharmacology; Internal medicine","score_opus":0.45305085717861787,"score_gpt":0.6046495154727972,"score_spread":0.15159865829417934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070243746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002914753,0.99600655,0.0008496397,0.0005311772,0.00021451946,0.000015841712,0.000039094215,0.00002625931,0.002025479],"genre_scores_gemma":[0.0014475173,0.9963212,0.00089474727,0.00028789748,0.0001390996,0.000014812492,0.000046263816,0.000004495996,0.0008439534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997911,0.000045033,0.000024093028,0.000030181642,0.00009068402,0.000018899333],"domain_scores_gemma":[0.999723,0.0001342168,0.00003612592,0.000010902473,0.00007250714,0.000023265797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061744865,0.00071850995,0.0014033193,0.0019431388,0.0002528018,0.000816684,0.00089130126,0.00094571686,0.004486033],"category_scores_gemma":[0.0008041917,0.00021383047,0.0006389831,0.0014908549,0.0003636112,0.0008703604,0.000632352,0.002156919,0.0030433785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000480808,0.00012830512,0.000103166785,0.00987001,0.00011250565,0.00014924434,0.00004168156,0.0006156491,0.0025952605,0.0059546917,0.021956367,0.9584251],"study_design_scores_gemma":[0.000052881387,0.00021000237,0.0006986944,0.003825542,0.00014955558,0.0014685206,0.000048346123,0.00047537594,0.0012522362,0.0056208665,0.986167,0.00003104189],"about_ca_topic_score_codex":0.00062922254,"about_ca_topic_score_gemma":0.001695968,"teacher_disagreement_score":0.004486033,"about_ca_system_score_codex":0.0004035204,"about_ca_system_score_gemma":0.0007797275,"threshold_uncertainty_score":0.015007257},"labels":[],"label_agreement":null},{"id":"W2072903209","doi":"10.1586/17512433.2014.913980","title":"Personalized pharmacotherapy in diabetes care using clinical pharmacology data of basal insulin analogues","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Kingston General Hospital","funders":"","keywords":"Medicine; Clinical pharmacology; Insulin; Basal insulin; Pharmacotherapy; Diabetes mellitus; Pharmacology; Basal (medicine); Clinical Practice; Drug; Personalized medicine; Type 2 diabetes; Bioinformatics; Internal medicine; Endocrinology; Biology","score_opus":0.37505185735522667,"score_gpt":0.6371617593276121,"score_spread":0.26210990197238543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072903209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019095883,0.9968066,0.0005890366,0.0006771005,0.00016836058,0.000015750064,0.00002818306,0.0000097989105,0.0015140537],"genre_scores_gemma":[0.0020471662,0.9960134,0.00080316263,0.00044218835,0.00023269556,0.000016629121,0.00004259081,0.000002052501,0.0004002069],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993445,0.00021567318,0.0000969117,0.00007235723,0.0002361775,0.000034440836],"domain_scores_gemma":[0.9990765,0.00058941485,0.000112645306,0.000023116501,0.00016887438,0.00002938503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013859901,0.00077938096,0.0017744015,0.0020132803,0.0001891178,0.0013956658,0.00088979845,0.0012311689,0.0033888107],"category_scores_gemma":[0.0017590214,0.00021202966,0.0012381945,0.001622705,0.00044104748,0.0011220686,0.0007124592,0.0021320912,0.0013806084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009144443,0.000102166494,0.00034899026,0.028215047,0.00033774722,0.00027940742,0.000073209354,0.00050433585,0.0014665936,0.006464031,0.013256167,0.9488608],"study_design_scores_gemma":[0.000079429774,0.00025248338,0.0023079698,0.020094287,0.0007692965,0.0027049426,0.00013672397,0.0004746604,0.0010972657,0.0074944324,0.96452546,0.00006294508],"about_ca_topic_score_codex":0.00076065,"about_ca_topic_score_gemma":0.0014836327,"teacher_disagreement_score":0.0033888107,"about_ca_system_score_codex":0.00062050094,"about_ca_system_score_gemma":0.0011911477,"threshold_uncertainty_score":0.011336744},"labels":[],"label_agreement":null},{"id":"W2074592693","doi":"10.1586/ecp.11.71","title":"Macrocyclic antibiotics: a novel class of drug for the treatment of<i>Clostridium difficile</i>infection","year":2011,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital; Saskatchewan Health Authority","funders":"","keywords":"Medicine; Clostridium difficile; Antibiotics; Antimicrobial; Drug; Microbiology; Intensive care medicine; Pharmacology; Biology","score_opus":0.08400978777234012,"score_gpt":0.475008023608945,"score_spread":0.39099823583660487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074592693","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013675468,0.09143749,0.0002693665,0.035100017,0.8711539,0.000038385067,0.000059441638,0.000049723072,0.0017549765],"genre_scores_gemma":[0.001244449,0.09212397,0.00031258172,0.03893832,0.85857135,0.00003328415,0.000051230483,0.000026594606,0.0086982045],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984054,0.00037602312,0.0002640964,0.00013920513,0.0007287007,0.00008657286],"domain_scores_gemma":[0.9949191,0.0023993705,0.0004355589,0.00008425757,0.0016377734,0.00052386534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036695735,0.0018169156,0.0018384483,0.001774268,0.0010254786,0.002983914,0.0019085057,0.0064091813,0.0034480074],"category_scores_gemma":[0.006694363,0.00050512736,0.0013832577,0.0009573647,0.0013384726,0.0023140537,0.0007288665,0.009381265,0.0032906812],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007993107,0.000015007593,0.000024853924,0.00087531336,0.00003082564,0.00014005695,0.000016135427,0.000035249806,0.00016861032,0.00041619493,0.97642183,0.021775877],"study_design_scores_gemma":[0.0001240757,0.00013339783,0.00025923873,0.0007659773,0.00010060048,0.00066256186,0.00003037392,0.000115423856,0.0002515277,0.00059706334,0.99694234,0.000017347898],"about_ca_topic_score_codex":0.00081593834,"about_ca_topic_score_gemma":0.0032658705,"teacher_disagreement_score":0.0064091813,"about_ca_system_score_codex":0.001314985,"about_ca_system_score_gemma":0.0018109521,"threshold_uncertainty_score":0.019406796},"labels":[],"label_agreement":null},{"id":"W2079915635","doi":"10.1586/ecp.10.22","title":"Welcome to ‘Clinical Pharmacology of Ion Channels’","year":2010,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Clinical pharmacology; Ion channel; Pharmacology; Neuroscience; Internal medicine; Receptor","score_opus":0.06321268307145342,"score_gpt":0.4798959462211461,"score_spread":0.41668326314969273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079915635","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038838774,0.05660473,0.0016310913,0.28559527,0.64335024,0.00016356359,0.00012467398,0.00026872242,0.011873336],"genre_scores_gemma":[0.0018132956,0.023310037,0.0017973761,0.2258534,0.67206264,0.0001102718,0.00020955628,0.0001713962,0.07467205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961124,0.0009028493,0.00029500687,0.0005913361,0.0015643891,0.00053413113],"domain_scores_gemma":[0.97937316,0.005836228,0.0011369459,0.0008705762,0.0068198615,0.0059632706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055387304,0.0021695348,0.0028036626,0.0023856892,0.0013234674,0.0042546294,0.0033686147,0.021698503,0.051344533],"category_scores_gemma":[0.016645782,0.00081857835,0.0025055015,0.0011776362,0.002104974,0.0055986578,0.003865223,0.015770145,0.02799549],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014853849,0.000053540494,0.000060955717,0.0003220832,0.000019838099,0.00035622402,0.00001670379,0.00005408922,0.000553674,0.0011149591,0.95982087,0.03747847],"study_design_scores_gemma":[0.00015976031,0.00017508042,0.00057828694,0.00027403526,0.000030951192,0.00093377207,0.00003664475,0.00010585969,0.00019449253,0.0021843947,0.99529016,0.00003646914],"about_ca_topic_score_codex":0.0009554624,"about_ca_topic_score_gemma":0.002777295,"teacher_disagreement_score":0.051344533,"about_ca_system_score_codex":0.0015112564,"about_ca_system_score_gemma":0.0028715995,"threshold_uncertainty_score":0.17176455},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2086704957","doi":"10.1586/17512433.2015.1018182","title":"Pharmacological strategies for prevention of postoperative atrial fibrillation","year":2015,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Aurora Foundation; Aurora Research Institute","keywords":"Medicine; Atrial fibrillation; Pathophysiology; Myocardial infarction; Cardiology; Heart failure; Cardiac surgery; Internal medicine; Incidence (geometry); Stroke (engine); Intensive care medicine","score_opus":0.4085152116518038,"score_gpt":0.6236671534498444,"score_spread":0.21515194179804054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086704957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023407824,0.9978381,0.00014919114,0.000432056,0.00013265932,0.0000099457675,0.00003306724,0.000008698571,0.0011622283],"genre_scores_gemma":[0.0014202135,0.99750656,0.00025080369,0.00025054932,0.00012756012,0.0000107402,0.000035711837,0.0000013009029,0.00039665063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975437,0.000057039888,0.000052091218,0.000035267727,0.00008169784,0.000019638133],"domain_scores_gemma":[0.99967206,0.00018767135,0.000054840744,0.000008567751,0.00006273232,0.000014159283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046645664,0.00055227196,0.0010176484,0.001626447,0.00021181526,0.00082132674,0.00060222985,0.0009375732,0.005859897],"category_scores_gemma":[0.0008940434,0.00015276542,0.0010180145,0.00077158946,0.00026480682,0.00073040096,0.0004938961,0.0015705887,0.0015400809],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013291197,0.00021412021,0.00035280813,0.038042378,0.00032985344,0.00027472037,0.00008222086,0.00032591276,0.0019133502,0.0039685066,0.020292457,0.9340707],"study_design_scores_gemma":[0.000099816774,0.00039988905,0.0024348868,0.020384587,0.0007080976,0.0025210727,0.00011682714,0.0002683691,0.0010517682,0.0041941376,0.9677852,0.000035421563],"about_ca_topic_score_codex":0.0006042825,"about_ca_topic_score_gemma":0.001281344,"teacher_disagreement_score":0.005859897,"about_ca_system_score_codex":0.00031961803,"about_ca_system_score_gemma":0.0007769931,"threshold_uncertainty_score":0.019603372},"labels":[],"label_agreement":null},{"id":"W2093908956","doi":"10.1586/ecp.13.15","title":"The potential and promise of mefenamic acid","year":2013,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Mefenamic acid; Medicine; Pharmacology; Drug","score_opus":0.0682458797305156,"score_gpt":0.5103905814010125,"score_spread":0.44214470167049685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093908956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016164784,0.99776876,0.000101248705,0.00058509974,0.00017146287,0.0000018976493,0.000008319405,0.000004639132,0.0011969022],"genre_scores_gemma":[0.0013787458,0.9971148,0.00016417407,0.0003308223,0.00028363924,0.0000034823465,0.000015324445,0.000001160558,0.0007078633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998054,0.00004456259,0.00002585902,0.000029945453,0.00007431693,0.000019843861],"domain_scores_gemma":[0.99978405,0.00008885912,0.000029684394,0.0000072534417,0.00006394706,0.000026185946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058333133,0.00051115046,0.0009074009,0.0016531604,0.0002535658,0.0009861679,0.00062232185,0.0011952394,0.0037978385],"category_scores_gemma":[0.00055940024,0.00015521827,0.00046785866,0.0009907085,0.0005022953,0.0015144979,0.0006915056,0.0019340853,0.001739429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012973689,0.00011431064,0.00021822406,0.014605288,0.000077741795,0.000524534,0.000120234086,0.0002901257,0.004897079,0.010259218,0.025786309,0.9429772],"study_design_scores_gemma":[0.000018831235,0.00010267627,0.000491431,0.0018044546,0.000047914164,0.00161369,0.00006976072,0.000080882564,0.0006643363,0.0032973946,0.991795,0.000013630879],"about_ca_topic_score_codex":0.00071874826,"about_ca_topic_score_gemma":0.00165694,"teacher_disagreement_score":0.0037978385,"about_ca_system_score_codex":0.00049441634,"about_ca_system_score_gemma":0.0008691475,"threshold_uncertainty_score":0.012705028},"labels":[],"label_agreement":null},{"id":"W2094669820","doi":"10.1586/ecp.10.123","title":"Follow-through after breakthrough","year":2010,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"","keywords":"Medicine; Intensive care medicine; Pharmacology","score_opus":0.0403159750612065,"score_gpt":0.4833199032850764,"score_spread":0.4430039282238699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094669820","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046177566,0.25116873,0.018722687,0.22762348,0.0487469,0.0009875505,0.0030907406,0.0019498755,0.40153244],"genre_scores_gemma":[0.35648912,0.14549379,0.009315125,0.10630666,0.017216153,0.00070393796,0.0034904226,0.0006695488,0.3603152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986896,0.00029643456,0.00007364956,0.00018346003,0.0003433265,0.00041344142],"domain_scores_gemma":[0.99702233,0.0007655231,0.00032841496,0.0004894129,0.0006056277,0.0007886271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003085496,0.00068500324,0.00079834415,0.0009871306,0.0010884674,0.0025125628,0.00095004187,0.0027863095,0.059710883],"category_scores_gemma":[0.00865665,0.00016637112,0.0008780608,0.00095554034,0.00060974504,0.0029211503,0.0019028361,0.0033764874,0.018519139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008285533,0.00052517117,0.0024469753,0.0014931834,0.00011252479,0.0015180726,0.00033210267,0.0003417628,0.0020290047,0.021513144,0.2986301,0.6702294],"study_design_scores_gemma":[0.0002848641,0.00075768196,0.004421674,0.0008790677,0.00010089216,0.0021593892,0.00035477953,0.00017132213,0.001964214,0.014761303,0.97411275,0.000032092692],"about_ca_topic_score_codex":0.0015041756,"about_ca_topic_score_gemma":0.002461111,"teacher_disagreement_score":0.059710883,"about_ca_system_score_codex":0.001464845,"about_ca_system_score_gemma":0.0037002675,"threshold_uncertainty_score":0.19975281},"labels":[],"label_agreement":null},{"id":"W2100338188","doi":"10.1586/17512433.2014.904744","title":"A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":259,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Acetaminophen; Medicine; Analgesic; acetaminophen overdose; Toxicity; Drug overdose; Opioid; Epidemiology; Anesthesia; Pharmacology; Intensive care medicine; Poison control; Acetylcysteine; Emergency medicine; Internal medicine","score_opus":0.4224043631539794,"score_gpt":0.6106134601020781,"score_spread":0.18820909694809868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100338188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021774441,0.99586344,0.00012661771,0.0022999996,0.00027414502,0.0000042654246,0.00012522447,0.000006618198,0.0010819446],"genre_scores_gemma":[0.0013943276,0.9972255,0.00018096447,0.00055995816,0.0003069878,0.0000048719935,0.000084683474,9.902785e-7,0.00024171677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999564,0.00011330355,0.00008933377,0.000070653194,0.00013073311,0.000031927964],"domain_scores_gemma":[0.9988263,0.00044310006,0.00025485276,0.000016043936,0.0003926051,0.00006710836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092462124,0.0006031162,0.0008528348,0.0042212284,0.0002771351,0.001129735,0.0006010326,0.0011404157,0.0046450174],"category_scores_gemma":[0.0019740579,0.00022119294,0.00095226115,0.0040792613,0.00031675113,0.0012846016,0.000589959,0.0014045815,0.001102116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080827944,0.00007815144,0.0055356612,0.02609046,0.00037980982,0.00035792042,0.00025441925,0.00036220372,0.0005356264,0.0058926693,0.09021701,0.8702152],"study_design_scores_gemma":[0.000016587246,0.00016276109,0.023067502,0.04195619,0.0006576222,0.0035073902,0.00071061373,0.00020246985,0.0001985702,0.0031285423,0.9263305,0.00006125087],"about_ca_topic_score_codex":0.009013667,"about_ca_topic_score_gemma":0.010846847,"teacher_disagreement_score":0.009013667,"about_ca_system_score_codex":0.0010139148,"about_ca_system_score_gemma":0.002527102,"threshold_uncertainty_score":0.017922401},"labels":[],"label_agreement":null},{"id":"W2106544163","doi":"10.1586/ecp.09.5","title":"Cyclobenzaprine: a new look at an old pharmacological agent","year":2009,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Medicine; Tricyclic; Anticholinergic; Fibromyalgia; Intensive care medicine; Drug; Pharmacology; Psychiatry","score_opus":0.11779674360950539,"score_gpt":0.5229288800432607,"score_spread":0.4051321364337553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106544163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007816629,0.9603444,0.0010270488,0.027403101,0.0030577648,0.00001212454,0.000021333726,0.000037110185,0.0073155034],"genre_scores_gemma":[0.0077100066,0.95345134,0.0016846588,0.018003868,0.008382053,0.000023633173,0.000030841464,0.00002029763,0.010693295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953437,0.00012752529,0.00004282918,0.00008373512,0.00016974068,0.000041811996],"domain_scores_gemma":[0.9992163,0.00034232048,0.000057070985,0.00003465438,0.00025498413,0.00009459856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010949251,0.0005865417,0.0013255659,0.0015973641,0.00066236785,0.0025361148,0.0009195401,0.0026281357,0.0060405866],"category_scores_gemma":[0.0010642507,0.0002438754,0.00048903626,0.0009889723,0.002200712,0.0051107486,0.00096297596,0.0055578337,0.0030352671],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029966776,0.00024056199,0.0005984931,0.0049361885,0.00004656943,0.0016881716,0.00063219067,0.00015799869,0.005462346,0.034579918,0.109421745,0.8419361],"study_design_scores_gemma":[0.000039311144,0.00027818157,0.0006241987,0.00164817,0.000028280156,0.0038359964,0.00036350018,0.00012745472,0.00059912936,0.011718229,0.98070544,0.00003217699],"about_ca_topic_score_codex":0.0008591082,"about_ca_topic_score_gemma":0.0023172318,"teacher_disagreement_score":0.0060405866,"about_ca_system_score_codex":0.0010941728,"about_ca_system_score_gemma":0.00086838804,"threshold_uncertainty_score":0.020207703},"labels":[],"label_agreement":null},{"id":"W2115180385","doi":"10.1586/17512433.2.2.181","title":"Lipid-based delivery of CpG oligodeoxynucleotides for cancer immunotherapy","year":2009,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"CpG Oligodeoxynucleotide; Medicine; Biodistribution; Immunotherapy; Immune system; Cancer; Cancer research; Pharmacology; Cancer immunotherapy; Clinical trial; Monoclonal antibody; Immunology; Antibody; In vitro; Biology; Internal medicine; Biochemistry; DNA methylation","score_opus":0.04964886940516828,"score_gpt":0.46639185258536986,"score_spread":0.4167429831802016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115180385","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40048847,0.35371733,0.20811191,0.0030001735,0.00077317544,0.0010192478,0.0003980816,0.00080932287,0.031682324],"genre_scores_gemma":[0.67508245,0.21539037,0.08598293,0.0009851486,0.00018548722,0.00042485422,0.0004328286,0.00007593275,0.021439964],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999192,0.00001730935,0.000004643397,0.000013242713,0.0000352293,0.000010277411],"domain_scores_gemma":[0.9999778,0.0000055441496,0.0000057240686,0.0000014927,0.0000047603958,0.000004646358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002480361,0.0002897412,0.0002918936,0.00035550908,0.00012204407,0.00027067625,0.00019330217,0.00039489658,0.00078033697],"category_scores_gemma":[0.000103212195,0.00011389072,0.00019637466,0.0002206015,0.00023580351,0.00024369899,0.00025928923,0.00049339945,0.0005842324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009071673,0.00007430305,0.00008979051,0.00050579733,0.000013641766,0.00014744929,0.00003015676,0.0009821216,0.9248436,0.0018869299,0.00047532527,0.0708601],"study_design_scores_gemma":[0.0001342654,0.0012817011,0.00082067476,0.00013390198,0.000067755405,0.0011645501,0.000034793808,0.004186126,0.8924988,0.0016249934,0.09802042,0.00003190555],"about_ca_topic_score_codex":0.00058883097,"about_ca_topic_score_gemma":0.00089111185,"teacher_disagreement_score":0.00078033697,"about_ca_system_score_codex":0.0005157865,"about_ca_system_score_gemma":0.0004545544,"threshold_uncertainty_score":0.0037423372},"labels":[],"label_agreement":null},{"id":"W2124551261","doi":"10.1586/ecp.10.16","title":"Strategies for the real-time detection of Ca<sup>2+</sup>channel events of single cells: recent advances and new possibilities","year":2010,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine","score_opus":0.09645986708757702,"score_gpt":0.4348078142889891,"score_spread":0.3383479472014121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124551261","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021668365,0.4619844,0.5026095,0.003802233,0.0013891825,0.00025680778,0.00044921192,0.0020155786,0.0058248052],"genre_scores_gemma":[0.10315361,0.31002674,0.572762,0.0037859746,0.0014703643,0.0010002643,0.0006698733,0.00037024982,0.006760857],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982601,0.00041542307,0.00012298506,0.0004240673,0.00068332045,0.00009416642],"domain_scores_gemma":[0.99797064,0.0010648491,0.00027550536,0.00022566007,0.00035523126,0.000108065855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027971803,0.0015096692,0.0026680694,0.0012455087,0.0003879394,0.0018000632,0.0023989347,0.0019407553,0.0026009926],"category_scores_gemma":[0.0017708037,0.0007736897,0.000875577,0.001041629,0.0017594529,0.0030931071,0.0013367019,0.0027523115,0.0022932813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028350516,0.00010154637,0.00077997084,0.0036584125,0.00010495379,0.00026353908,0.00020953688,0.0006100166,0.7175504,0.0053022746,0.0035042167,0.26763174],"study_design_scores_gemma":[0.000106363164,0.0010390535,0.0043754117,0.0005278508,0.00031448825,0.0037922012,0.0003684998,0.010919622,0.8004281,0.010546422,0.1673159,0.000266025],"about_ca_topic_score_codex":0.00034052233,"about_ca_topic_score_gemma":0.0005611874,"teacher_disagreement_score":0.0027971803,"about_ca_system_score_codex":0.00087637326,"about_ca_system_score_gemma":0.00056998146,"threshold_uncertainty_score":0.014793098},"labels":[],"label_agreement":null},{"id":"W2125393397","doi":"10.1586/17512433.2.1.87","title":"Iatrogenic glaucoma therapy failure: the adverse effects of topical antiglaucoma medication treatment outcome","year":2008,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Glaucoma; Trabeculectomy; Adverse effect; Optic nerve; Optic neuropathy; Brimonidine; Medical therapy; Pharmacotherapy; Intensive care medicine; Ophthalmology; Dermatology; Surgery; Internal medicine","score_opus":0.05212792360520359,"score_gpt":0.44261011502780534,"score_spread":0.39048219142260177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125393397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8142591,0.13846725,0.002714739,0.0053867297,0.00035276602,0.00017250163,0.0011867725,0.000076962024,0.037383176],"genre_scores_gemma":[0.9907769,0.0072588637,0.00041167723,0.0004028587,0.00025783115,0.000025685082,0.00018344882,0.000006244827,0.0006763738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723923,0.0009709831,0.00044661114,0.000105122504,0.0010919295,0.00014607626],"domain_scores_gemma":[0.9879401,0.0040118378,0.0057690907,0.00032750334,0.0014715061,0.00048000348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024670544,0.00019853638,0.0006140162,0.00077334436,0.00031040533,0.00069374754,0.00020497583,0.0004073152,0.0024485947],"category_scores_gemma":[0.008662671,0.000046674442,0.00065408944,0.00092581834,0.00034063339,0.00050744327,0.00040770078,0.0006142957,0.0003633801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012822639,0.00023572546,0.72641224,0.0009978213,0.0006415644,0.0021013457,0.00022137603,0.00038245163,0.00092546374,0.0005818442,0.0021583484,0.2640595],"study_design_scores_gemma":[0.000049411716,0.0015671721,0.9698318,0.00046032656,0.0007465876,0.012902787,0.00027431757,0.0010214049,0.0012605439,0.00096303585,0.010887106,0.00003538564],"about_ca_topic_score_codex":0.0007587409,"about_ca_topic_score_gemma":0.001455108,"teacher_disagreement_score":0.0024670544,"about_ca_system_score_codex":0.00050731417,"about_ca_system_score_gemma":0.00054669863,"threshold_uncertainty_score":0.013047159},"labels":[],"label_agreement":null},{"id":"W2125917241","doi":"10.1586/17512433.2014.928196","title":"Sofosbuvir (Sovaldi) for the treatment of hepatitis C","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sofosbuvir; Medicine; Simeprevir; Ribavirin; Hepatitis C; Pegylated interferon; Daclatasvir; Hepatitis C virus; Clinical trial; Pharmacology; Internal medicine; Intensive care medicine; Virology; Virus","score_opus":0.29471990705978673,"score_gpt":0.6339532387622916,"score_spread":0.33923333170250486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125917241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032442086,0.99722433,0.00016481901,0.00020417929,0.00020568729,0.000012638084,0.000036587364,0.000009270951,0.0018181085],"genre_scores_gemma":[0.0027245656,0.9949999,0.0003554376,0.0003425886,0.00016545707,0.000013985032,0.000088261775,0.0000023535529,0.0013074448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999821,0.000039867107,0.00002697096,0.000028814615,0.00006683065,0.000016564873],"domain_scores_gemma":[0.999861,0.00005305812,0.00003662028,0.0000044348308,0.000027756714,0.000017120306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004443914,0.00071638153,0.00090822787,0.0018766553,0.00025343482,0.000517112,0.000544523,0.00070111157,0.005201333],"category_scores_gemma":[0.00039624094,0.00016762332,0.0006524918,0.0014242303,0.0002612172,0.00055965787,0.00058515277,0.0015439057,0.00289464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010454723,0.00007371188,0.00014763586,0.011225227,0.00012583306,0.00017717436,0.00003951372,0.00016997209,0.0018709444,0.0013845987,0.016365916,0.968315],"study_design_scores_gemma":[0.00009689915,0.00021885555,0.0011748445,0.0035997257,0.00022931382,0.0023734206,0.000039091778,0.00008814056,0.0008977417,0.0012264263,0.99003524,0.000020240976],"about_ca_topic_score_codex":0.000738469,"about_ca_topic_score_gemma":0.0017265923,"teacher_disagreement_score":0.005201333,"about_ca_system_score_codex":0.00030754303,"about_ca_system_score_gemma":0.00072109886,"threshold_uncertainty_score":0.017400205},"labels":[],"label_agreement":null},{"id":"W2138802019","doi":"10.1586/ecp.10.133","title":"Hydrogen sulfide and the metabolic syndrome","year":2010,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Sulfur Compounds in Biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Hyperinsulinemia; Medicine; Hyperlipidemia; Metabolic syndrome; Internal medicine; Diabetes mellitus; Endocrinology; Vasodilation; Type 2 diabetes; Hydrogen sulfide; Blood pressure; Insulin resistance; Pharmacology; Chemistry","score_opus":0.06145998671178908,"score_gpt":0.4713678816675021,"score_spread":0.409907894955713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138802019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011043662,0.9977043,0.00007503436,0.00050155853,0.00023788042,0.0000038901426,0.000013194957,0.000007365036,0.0013462944],"genre_scores_gemma":[0.00064365094,0.9974987,0.00010552537,0.00029353725,0.00026279106,0.0000057700427,0.000028422686,0.0000010862204,0.0011603697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998648,0.000028211945,0.000014597328,0.00002039392,0.000057213678,0.00001485663],"domain_scores_gemma":[0.9998864,0.000032177188,0.00002020445,0.0000030017316,0.00003587342,0.000022232038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035042508,0.0009513117,0.0012694885,0.0015402738,0.00028120817,0.0007621602,0.0006565383,0.0013267398,0.004859709],"category_scores_gemma":[0.00031125467,0.00019448703,0.00032959357,0.0013888256,0.00035038698,0.00082452147,0.0006888237,0.0016116044,0.004027603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102360835,0.00010122698,0.00019735724,0.0075157885,0.000085227104,0.0003403698,0.000052124626,0.00021050364,0.0017942517,0.0035249616,0.06427141,0.9218045],"study_design_scores_gemma":[0.000041831914,0.00009377569,0.0010856309,0.002393047,0.000066211214,0.0019722993,0.000054916945,0.00008261624,0.00034472055,0.0026846442,0.99116254,0.00001772777],"about_ca_topic_score_codex":0.0012876029,"about_ca_topic_score_gemma":0.002620268,"teacher_disagreement_score":0.004859709,"about_ca_system_score_codex":0.0006539128,"about_ca_system_score_gemma":0.00094819075,"threshold_uncertainty_score":0.016257346},"labels":[],"label_agreement":null},{"id":"W2143171616","doi":"10.1586/17512433.1.1.73","title":"Integrating pharmacogenomics into oncology clinical practice","year":2008,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"U.S. Food and Drug Administration; Genome Canada","keywords":"Pharmacogenomics; Medicine; Irinotecan; Oncology; Genotyping; Internal medicine; Trastuzumab; Tamoxifen; Clinical trial; Clinical Oncology; Clinical Practice; Bioinformatics; Cancer; Colorectal cancer; Medical physics; Pharmacology; Genotype; Breast cancer; Family medicine; Genetics","score_opus":0.10807660934412486,"score_gpt":0.5524788650701478,"score_spread":0.4444022557260229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143171616","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004583493,0.11707951,0.13678549,0.6700008,0.0051445747,0.0004027141,0.00015889609,0.00070660264,0.06513794],"genre_scores_gemma":[0.17566614,0.31333715,0.305112,0.16933456,0.026501585,0.0006978479,0.00035837633,0.00036116247,0.008631233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97996944,0.0135542145,0.0011880125,0.0011124021,0.0037705433,0.0004054599],"domain_scores_gemma":[0.9617418,0.022030538,0.0021948284,0.0020274592,0.008439336,0.0035661324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034928553,0.0006866375,0.0012921675,0.003410754,0.0008542663,0.008213425,0.0019997347,0.004491213,0.0055621467],"category_scores_gemma":[0.06503633,0.0005223841,0.0005962319,0.0024069394,0.0051213256,0.0052589457,0.0052944315,0.007611382,0.0027726502],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006964844,0.0002857474,0.007890792,0.0015888313,0.00018032642,0.0008689251,0.0011847091,0.0047021513,0.0011065437,0.10365271,0.09023596,0.7882336],"study_design_scores_gemma":[0.00011598848,0.0003006569,0.007015986,0.0040445137,0.000100365025,0.0013637847,0.0016677201,0.004722727,0.0008737691,0.4298163,0.54986274,0.00011539941],"about_ca_topic_score_codex":0.0024901668,"about_ca_topic_score_gemma":0.0023106576,"teacher_disagreement_score":0.034928553,"about_ca_system_score_codex":0.0047935173,"about_ca_system_score_gemma":0.011461572,"threshold_uncertainty_score":0.184722},"labels":[],"label_agreement":null},{"id":"W2149842284","doi":"10.1586/ecp.10.130","title":"Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential","year":2010,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Sulfur Compounds in Biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pathogenesis; Hyperhomocysteinemia; Nitric oxide; Cystathionine beta synthase; Cystathionine gamma-lyase; Foam cell; Inflammation; Pharmacology; Bioinformatics; Homocysteine; Immunology; Cholesterol; Internal medicine; Biochemistry; Biology; Lipoprotein; Cysteine","score_opus":0.09260357773046925,"score_gpt":0.4664020495922916,"score_spread":0.37379847186182236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149842284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039008583,0.99693465,0.00016468111,0.0007512181,0.00029888688,0.000007192139,0.00003078226,0.000012939272,0.0014094827],"genre_scores_gemma":[0.0031874054,0.9942545,0.00022824656,0.0004738437,0.00039248852,0.00001593651,0.000073037736,0.000002509089,0.0013720121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985766,0.00003585857,0.000018923063,0.000021801989,0.000044606717,0.000021152362],"domain_scores_gemma":[0.99987626,0.00004288438,0.000021697915,0.0000032678945,0.00004080474,0.000015151269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046114982,0.00045388195,0.00079694105,0.001032834,0.00019147914,0.0007405702,0.0005023214,0.0012246321,0.0053064986],"category_scores_gemma":[0.00040441635,0.00014479182,0.0005230972,0.00056202087,0.0002189436,0.00059693324,0.0004586083,0.0011655621,0.0019925693],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033459466,0.00015242006,0.00030417318,0.018465668,0.00015870095,0.0005548447,0.00011029122,0.00044717515,0.0079575395,0.004842789,0.04722737,0.9194444],"study_design_scores_gemma":[0.00008124299,0.00029512495,0.0010954696,0.0035802685,0.00021321168,0.0016754571,0.00009106788,0.00021400249,0.0021964854,0.0031578694,0.98737,0.000029661376],"about_ca_topic_score_codex":0.00058595417,"about_ca_topic_score_gemma":0.0010777648,"teacher_disagreement_score":0.0053064986,"about_ca_system_score_codex":0.00037315884,"about_ca_system_score_gemma":0.000649143,"threshold_uncertainty_score":0.017752051},"labels":[],"label_agreement":null},{"id":"W2150595547","doi":"10.1586/17512433.2014.910111","title":"Understanding and preventing drug–drug and drug–gene interactions","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Institut Universitaire de Gériatrie de Montréal","funders":"","keywords":"Drug; Medicine; Pharmacology; Pharmacogenetics; Drug interaction; Drug action; Cytochrome P450; Drug metabolism; Pharmacogenomics; Computational biology; Gene; Biology; Genetics; Internal medicine; Genotype","score_opus":0.4669670775692211,"score_gpt":0.6204686295753388,"score_spread":0.15350155200611765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150595547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007113469,0.99230725,0.0015975614,0.0012778084,0.00020739938,0.00003455381,0.000080637525,0.000039774186,0.003743796],"genre_scores_gemma":[0.0038231614,0.99275655,0.0013436036,0.00054119993,0.00017647234,0.000025062585,0.00009968396,0.000005507095,0.0012287541],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950206,0.00012854656,0.00006088613,0.000064977205,0.00020692748,0.000036505433],"domain_scores_gemma":[0.9994466,0.00027739425,0.00009368018,0.00002165969,0.00013077873,0.000029914898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008381975,0.0008365525,0.0014664982,0.0023130632,0.00023212665,0.0009272697,0.00089315034,0.0012269439,0.0047437903],"category_scores_gemma":[0.0012158899,0.00021378662,0.00096005056,0.0012094945,0.00045313494,0.0010725234,0.0007193698,0.0015156103,0.0021018353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043564112,0.00012865075,0.00043288438,0.012044187,0.00016231925,0.00027047913,0.000047576134,0.0004560678,0.002541409,0.003349036,0.014231814,0.966292],"study_design_scores_gemma":[0.000035618265,0.00024162098,0.0025015282,0.0049378187,0.00033183143,0.0025762264,0.00008527868,0.00040020558,0.0027959656,0.0047062584,0.98134965,0.00003805637],"about_ca_topic_score_codex":0.0011199558,"about_ca_topic_score_gemma":0.0017780352,"teacher_disagreement_score":0.0047437903,"about_ca_system_score_codex":0.00045450567,"about_ca_system_score_gemma":0.0012017454,"threshold_uncertainty_score":0.015869558},"labels":[],"label_agreement":null},{"id":"W2155237015","doi":"10.1586/17512433.1.5.627","title":"Inflammatory reactions and drug response: importance of cytochrome P450 and membrane transporters","year":2008,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Drug; Pharmacology; Transporter; Cytochrome P450; ATP-binding cassette transporter; Biochemistry; Metabolism; Internal medicine; Chemistry","score_opus":0.041304335126176935,"score_gpt":0.4125003637328539,"score_spread":0.371196028606677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155237015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033375695,0.9328223,0.0054824976,0.013349297,0.0005320266,0.000056281136,0.00011139787,0.000079852514,0.014190603],"genre_scores_gemma":[0.27890077,0.69807905,0.0046063676,0.003560002,0.003046748,0.0000813664,0.00014658668,0.000026618085,0.011552538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994815,0.00022601898,0.00004854212,0.000054691533,0.0001323965,0.000056942645],"domain_scores_gemma":[0.9994067,0.00023347429,0.0001607246,0.000021331174,0.00012310238,0.000054727767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055949757,0.0004573709,0.0009259458,0.000493021,0.0002216684,0.00121054,0.00023264291,0.00091045897,0.0024870774],"category_scores_gemma":[0.00062645297,0.00013119182,0.00032261453,0.0004706005,0.00053755275,0.0009811756,0.0003693642,0.000964312,0.00056148303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013018758,0.00071396155,0.017528947,0.0059659984,0.00055172964,0.004327112,0.00045886636,0.001478556,0.09834158,0.023880634,0.01954731,0.82590336],"study_design_scores_gemma":[0.00040355686,0.004723314,0.22700024,0.0019829404,0.00074160093,0.03434859,0.0015509757,0.004522173,0.05909916,0.038123187,0.6273024,0.00020189094],"about_ca_topic_score_codex":0.0004545776,"about_ca_topic_score_gemma":0.00055849884,"teacher_disagreement_score":0.0024870774,"about_ca_system_score_codex":0.0004613738,"about_ca_system_score_gemma":0.00038760784,"threshold_uncertainty_score":0.008320034},"labels":[],"label_agreement":null},{"id":"W2159243900","doi":"10.1586/ecp.12.53","title":"Clinical trials involving the oncolytic virus, reovirus: ready for prime time?","year":2012,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Oncolytic virus; Medicine; Carboplatin; Clinical trial; Internal medicine; Oncology; Chemotherapy; Paclitaxel; Cancer; Virus; Virology; Cisplatin","score_opus":0.28820894615084236,"score_gpt":0.6059017138304686,"score_spread":0.3176927676796263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159243900","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15668789,0.73251396,0.01954739,0.02977631,0.0072343424,0.009280485,0.0017583349,0.00038961976,0.04281173],"genre_scores_gemma":[0.49339354,0.39773497,0.034297552,0.02640131,0.004274558,0.008790842,0.0029137852,0.000152119,0.0320413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990613,0.00060324976,0.000047637295,0.00010130892,0.00012480169,0.000061729304],"domain_scores_gemma":[0.99904495,0.0003720661,0.00021042203,0.00006329944,0.00011043589,0.00019886461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042934255,0.00047902612,0.001381343,0.00024786164,0.00016177024,0.001328302,0.0007284904,0.0023424458,0.0054071876],"category_scores_gemma":[0.0020366071,0.00017052528,0.00059567497,0.00039484407,0.00053625286,0.0008748061,0.00031249036,0.0021090154,0.0011943392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054028984,0.006329856,0.0013720889,0.0075304215,0.0006762191,0.00034835344,0.00020998185,0.0014380247,0.06033053,0.009618921,0.034776762,0.8233399],"study_design_scores_gemma":[0.11934832,0.21788804,0.0048731654,0.004107524,0.0012386792,0.0015559582,0.00029609646,0.0013782983,0.025768103,0.010744409,0.6127114,0.00008994659],"about_ca_topic_score_codex":0.00029203697,"about_ca_topic_score_gemma":0.0011048792,"teacher_disagreement_score":0.0054071876,"about_ca_system_score_codex":0.00064297434,"about_ca_system_score_gemma":0.0012216298,"threshold_uncertainty_score":0.022706091},"labels":[],"label_agreement":null},{"id":"W2171856054","doi":"10.1586/17512433.1.5.605","title":"Major malformations after first trimester exposure to aspirin and NSAIDs","year":2008,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Aspirin; Pharmacology; First trimester; Pregnancy; Internal medicine; Fetus","score_opus":0.0750737188366503,"score_gpt":0.47815359618923364,"score_spread":0.4030798773525833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171856054","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035202983,0.99522215,0.000060704555,0.00023172928,0.000035501915,0.000018588078,0.00011596407,0.0000019536444,0.00079300505],"genre_scores_gemma":[0.02499801,0.9736796,0.00039057163,0.00034534535,0.00010523457,0.00002763988,0.00013886738,0.0000014809489,0.00031330978],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998114,0.00053091865,0.000595608,0.00016679654,0.0005244231,0.000068325724],"domain_scores_gemma":[0.99032265,0.0066350764,0.0025813407,0.0000695349,0.00032274268,0.00006870972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015872009,0.00036205916,0.0018953598,0.0037532288,0.00024058757,0.00086379296,0.00040178886,0.00074672245,0.0028940828],"category_scores_gemma":[0.007932086,0.000282723,0.0015344439,0.0045547145,0.0004503823,0.00046055167,0.00038442656,0.00056084385,0.00020336646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015086862,0.00009062124,0.037695434,0.23964569,0.0044635567,0.0067471205,0.00061402505,0.0002234971,0.0021909864,0.0013245883,0.0059392727,0.6995565],"study_design_scores_gemma":[0.00077713036,0.0022299916,0.37051672,0.2642827,0.04431811,0.08985064,0.0016085649,0.00033384172,0.0049873823,0.0032925406,0.2176561,0.00014632975],"about_ca_topic_score_codex":0.0038563083,"about_ca_topic_score_gemma":0.008320065,"teacher_disagreement_score":0.0038563083,"about_ca_system_score_codex":0.0007612511,"about_ca_system_score_gemma":0.001742131,"threshold_uncertainty_score":0.009681642},"labels":[],"label_agreement":null},{"id":"W2195254757","doi":"10.1586/17512433.2016.1129896","title":"Transitional Pain Medicine: novel pharmacological treatments for the management of moderate to severe postsurgical pain","year":2015,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Pain management; Pain medicine; Anesthesia; Anesthesiology","score_opus":0.10306639285082494,"score_gpt":0.49263446091417434,"score_spread":0.3895680680633494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2195254757","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006271439,0.14815888,0.0002595882,0.027240334,0.8219349,0.000049254955,0.00007046846,0.0000692886,0.002154533],"genre_scores_gemma":[0.00052227825,0.14544022,0.00027978452,0.026636815,0.81923944,0.000040897692,0.00006160973,0.000029799166,0.0077491226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967424,0.0006882042,0.00053298904,0.00026491977,0.0016184411,0.00015294558],"domain_scores_gemma":[0.99111146,0.0042158375,0.00065004895,0.0001723444,0.0029742045,0.0008761516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004880609,0.002839465,0.002935718,0.0028069213,0.0012627322,0.003947703,0.002964108,0.007907767,0.0061501237],"category_scores_gemma":[0.012299679,0.00072636915,0.0025669304,0.0014334557,0.0014120634,0.003689591,0.0012866486,0.015917659,0.0063002016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007831087,0.000032031956,0.000027032946,0.0014930684,0.000055243796,0.00008116456,0.000022095735,0.000039849478,0.00012376024,0.00045453644,0.95736724,0.040225565],"study_design_scores_gemma":[0.00014860669,0.00011728422,0.0003135894,0.0025284009,0.00014844578,0.00036226062,0.000046263434,0.00014746358,0.00013324778,0.0011902006,0.99483657,0.000027766706],"about_ca_topic_score_codex":0.0012575095,"about_ca_topic_score_gemma":0.0048173065,"teacher_disagreement_score":0.007907767,"about_ca_system_score_codex":0.0019606824,"about_ca_system_score_gemma":0.0032264797,"threshold_uncertainty_score":0.025811434},"labels":[],"label_agreement":null},{"id":"W2201080195","doi":"10.1586/17512433.2016.1112265","title":"Pharmacological approaches to CNS vasculitis: where are we at now?","year":2015,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Vasculitis; Azathioprine; Methotrexate; Intensive care medicine; Cyclophosphamide; Refractory (planetary science); Disease; Immunology; Internal medicine; Chemotherapy","score_opus":0.4049237408769511,"score_gpt":0.5265497279657719,"score_spread":0.12162598708882083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201080195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004524214,0.9989586,0.000048375023,0.0005158949,0.0001241545,0.0000022218367,0.0000059990166,0.0000032179828,0.00029626032],"genre_scores_gemma":[0.00042941427,0.9988255,0.000095274394,0.00032929485,0.0001619657,0.0000034393395,0.000009454032,8.5277026e-7,0.00014476855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996908,0.00008077787,0.00006871127,0.000046711913,0.00008793075,0.000025068173],"domain_scores_gemma":[0.99918216,0.000517461,0.000095864125,0.000022668326,0.00014603669,0.000035810775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008225353,0.00070389966,0.001878606,0.0017624209,0.00035729952,0.0012866411,0.000955192,0.0012970287,0.0036472238],"category_scores_gemma":[0.0014990759,0.00025395365,0.0008519292,0.001588685,0.0006835893,0.0017786582,0.00065379095,0.002564775,0.001232321],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008188517,0.00007408426,0.00017296399,0.029978562,0.00017442818,0.0002065135,0.00008848766,0.00020741018,0.00042550982,0.0027750365,0.029200332,0.9366148],"study_design_scores_gemma":[0.000062864805,0.00013947843,0.0015084179,0.02467477,0.00036521975,0.0028757118,0.00019740891,0.00013522233,0.00025515008,0.004723171,0.96502763,0.00003496388],"about_ca_topic_score_codex":0.0014245713,"about_ca_topic_score_gemma":0.00306535,"teacher_disagreement_score":0.0036472238,"about_ca_system_score_codex":0.0006306457,"about_ca_system_score_gemma":0.001200831,"threshold_uncertainty_score":0.01220125},"labels":[],"label_agreement":null},{"id":"W2462927708","doi":"10.1080/17512433.2016.1206467","title":"Tavaborole – a treatment for onychomycosis of the toenails","year":2016,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Nail (fastener); Dermatology; Nail disease; Pharmacodynamics; Antifungal; Adverse effect; Antifungal drugs; Intensive care medicine; Drug; Terbinafine; Pharmacokinetics; Pharmacology; Itraconazole; Psoriasis","score_opus":0.1985790396800821,"score_gpt":0.6048676893210374,"score_spread":0.40628864964095535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462927708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035858311,0.9962031,0.00012901133,0.0009353317,0.0003576869,0.000008595897,0.000031263622,0.000008666787,0.001967781],"genre_scores_gemma":[0.004333579,0.99269074,0.00023351544,0.0009694887,0.00030102738,0.000008970773,0.00004827562,0.0000020878635,0.001412316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981695,0.000043541804,0.000026157002,0.000032352244,0.00006778486,0.000013293121],"domain_scores_gemma":[0.99983954,0.00007592041,0.00003424894,0.0000035564065,0.00003718985,0.000009567827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027765112,0.00032177076,0.00055145693,0.0010204829,0.00020622261,0.00051844557,0.0004540038,0.00085188576,0.00444626],"category_scores_gemma":[0.0004909201,0.00010702923,0.00047110746,0.00062300457,0.00028809704,0.00057476043,0.00027718215,0.0012600044,0.0013321907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014146263,0.000075060976,0.00023038335,0.032528684,0.00014148287,0.00052953034,0.00009194752,0.00021048784,0.0039767935,0.0034740418,0.045503613,0.9130964],"study_design_scores_gemma":[0.000060754086,0.00019855709,0.0015576864,0.011622034,0.00019263063,0.0062615774,0.000100370526,0.000103601174,0.001508433,0.0015382532,0.97683525,0.00002069926],"about_ca_topic_score_codex":0.0008340124,"about_ca_topic_score_gemma":0.002144662,"teacher_disagreement_score":0.00444626,"about_ca_system_score_codex":0.00026798723,"about_ca_system_score_gemma":0.0005727051,"threshold_uncertainty_score":0.01487422},"labels":[],"label_agreement":null},{"id":"W2522764002","doi":"10.1080/17512433.2016.1238762","title":"Herbal medicines: challenges in the modern world. Part 4. Canada and United States","year":2016,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Alternative medicine; Product (mathematics); Traditional medicine; Legislature; Quality (philosophy); Family medicine; Political science","score_opus":0.2934660403446119,"score_gpt":0.555482747077806,"score_spread":0.2620167067331941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522764002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009404728,0.99389184,0.000028087388,0.002884418,0.00043038363,0.0000062971885,0.000035387202,0.0000044149942,0.0026251355],"genre_scores_gemma":[0.0014205949,0.9946791,0.00010824582,0.0020656358,0.00021625527,0.0000075603766,0.00003058815,0.0000019122538,0.0014700409],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992192,0.00011049128,0.000087615605,0.00006877448,0.00041221775,0.00010164936],"domain_scores_gemma":[0.99867636,0.00031201355,0.00019140991,0.000025603254,0.0006500893,0.000144385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011720418,0.0007001421,0.0012225681,0.0033706997,0.0011945138,0.0030340278,0.0009579896,0.0023436886,0.011564269],"category_scores_gemma":[0.0018931237,0.00029042433,0.0007960674,0.005440645,0.0019871716,0.0019316771,0.0010710685,0.0022747612,0.0015562663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009245045,0.000063901774,0.00046879117,0.049115114,0.00008058106,0.00047146782,0.0006590211,0.00028119478,0.0006945647,0.0153184915,0.15765569,0.7750988],"study_design_scores_gemma":[0.000010029046,0.000020311387,0.0018923488,0.020869002,0.00007370535,0.0005415131,0.00043908006,0.000038287893,0.000094902185,0.0012823946,0.974719,0.000019399198],"about_ca_topic_score_codex":0.3765751,"about_ca_topic_score_gemma":0.567254,"teacher_disagreement_score":0.6234249,"about_ca_system_score_codex":0.01124471,"about_ca_system_score_gemma":0.032768264,"threshold_uncertainty_score":0.7487664},"labels":[],"label_agreement":null},{"id":"W2522925890","doi":"10.1080/17512433.2016.1240029","title":"Methodological issues associated with clinical trials in neuropathic pain","year":2016,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Neuropathic pain; Clinical trial; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.49701399464965657,"score_gpt":0.6365394924654014,"score_spread":0.13952549781574486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522925890","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009821606,0.17284887,0.0031965158,0.12915488,0.69260275,0.00016186484,0.0001781505,0.00014341126,0.001615292],"genre_scores_gemma":[0.0019859439,0.039380614,0.0045663314,0.12208655,0.8290044,0.00040517503,0.00004618268,0.00014274163,0.0023820181],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.78999126,0.1214592,0.03979184,0.0076559437,0.03946107,0.0016407169],"domain_scores_gemma":[0.2868775,0.63457173,0.020127505,0.0100483745,0.044629417,0.0037454118],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20500304,0.004096885,0.012093638,0.0062105614,0.0028562027,0.010943375,0.008114448,0.030531015,0.0056913495],"category_scores_gemma":[0.48023388,0.0028369832,0.005729638,0.004420552,0.010771918,0.008146175,0.0033011436,0.03635945,0.0041321525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005232651,0.00004025286,0.00014546324,0.014520815,0.0013588322,0.00025013086,0.00018216856,0.00012862378,0.0001501685,0.0042807865,0.9112857,0.06713379],"study_design_scores_gemma":[0.0017998877,0.00024179989,0.0010982343,0.022123696,0.0031187157,0.00081061403,0.00020055973,0.0012150187,0.0004512211,0.031299494,0.9374453,0.0001955371],"about_ca_topic_score_codex":0.0014427003,"about_ca_topic_score_gemma":0.004339371,"teacher_disagreement_score":0.794997,"about_ca_system_score_codex":0.005426822,"about_ca_system_score_gemma":0.0074605304,"threshold_uncertainty_score":0.9803728},"labels":[],"label_agreement":null},{"id":"W2556384452","doi":"10.1080/17512433.2017.1260000","title":"Elosulfase alfa (BMN 110) for the treatment of mucopolysaccharidosis IVA (Morquio A Syndrome)","year":2016,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"BioMarin Pharmaceutical","keywords":"Medicine; Mucopolysaccharidosis; Internal medicine; Pediatrics","score_opus":0.20244798703558614,"score_gpt":0.5723343688873195,"score_spread":0.36988638185173334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556384452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009028286,0.9596481,0.000801554,0.028402556,0.0038695633,0.000032763943,0.00020191279,0.00003157125,0.006109281],"genre_scores_gemma":[0.02082443,0.9277901,0.0014337073,0.03679094,0.0050248993,0.000079986894,0.00036848328,0.000021317688,0.007666142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944764,0.0002577455,0.00007323587,0.000055959757,0.00013506155,0.000030249637],"domain_scores_gemma":[0.9991547,0.0004544317,0.00015613264,0.000014428984,0.00018971165,0.00003052461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011043577,0.0002992398,0.0006663247,0.00046600465,0.00016018235,0.0005396452,0.0005440291,0.0013692047,0.0036190744],"category_scores_gemma":[0.0026814674,0.00007855556,0.00056277885,0.00038928216,0.0003331158,0.00051001087,0.00035589092,0.001772638,0.0017466856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064588484,0.000039796818,0.00034395762,0.017888976,0.0003134032,0.000941784,0.00011463194,0.0004130242,0.0023940513,0.006058382,0.34478158,0.6260645],"study_design_scores_gemma":[0.0002623117,0.00018443352,0.0008366645,0.013109903,0.00025556094,0.0031219223,0.00006256255,0.00015337365,0.0008961465,0.0032411148,0.9778486,0.000027449856],"about_ca_topic_score_codex":0.0009136965,"about_ca_topic_score_gemma":0.0020081487,"teacher_disagreement_score":0.0036190744,"about_ca_system_score_codex":0.0005667571,"about_ca_system_score_gemma":0.0007390692,"threshold_uncertainty_score":0.012107015},"labels":[],"label_agreement":null},{"id":"W2561783875","doi":"10.1080/17512433.2017.1274651","title":"Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelines","year":2016,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Renal function; Impaired renal function; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.1340074352245196,"score_gpt":0.5498879234359803,"score_spread":0.4158804882114606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561783875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017969232,0.9660379,0.0010794607,0.026359793,0.0022155137,0.00007336385,0.00027195425,0.00004039842,0.0037418238],"genre_scores_gemma":[0.0016570026,0.9750507,0.0035498622,0.01569828,0.002450233,0.00013040376,0.00030897922,0.000022851711,0.0011316799],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98993486,0.0036940004,0.0026686785,0.0006542435,0.0028062488,0.00024199649],"domain_scores_gemma":[0.9431919,0.03403978,0.0055934563,0.0010422905,0.015429057,0.0007035706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019177947,0.00093751337,0.002774371,0.0046537314,0.00054492673,0.0031044865,0.0028069427,0.005393846,0.0046364604],"category_scores_gemma":[0.039191093,0.00068955205,0.0027793203,0.0048188707,0.0015389279,0.0045635724,0.0014862502,0.0070616156,0.0026001835],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013746771,0.000072744726,0.00056058937,0.041547127,0.00026022978,0.0002895337,0.0003144032,0.00037329755,0.00083253364,0.015067745,0.26479334,0.675751],"study_design_scores_gemma":[0.0000337314,0.000053592463,0.0010036913,0.029378254,0.00025063165,0.0006391266,0.000086151595,0.00010906598,0.00016931017,0.0031162088,0.96512836,0.00003184106],"about_ca_topic_score_codex":0.003947396,"about_ca_topic_score_gemma":0.0064185164,"teacher_disagreement_score":0.019177947,"about_ca_system_score_codex":0.002789551,"about_ca_system_score_gemma":0.009185683,"threshold_uncertainty_score":0.10142386},"labels":[],"label_agreement":null},{"id":"W2888588658","doi":"10.1080/17512433.2018.1516142","title":"Opioids in Ontario: the current state of affairs and a path forward","year":2018,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; St. Michael's Hospital","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Opioid; Current (fluid); Path (computing); State (computer science); Opioid epidemic; Internal medicine","score_opus":0.03615059706723368,"score_gpt":0.46373911014355446,"score_spread":0.4275885130763208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888588658","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009542966,0.13738476,0.0001386711,0.2136534,0.6441031,0.000029579147,0.0001999255,0.00006535714,0.004329719],"genre_scores_gemma":[0.0013674763,0.19744542,0.0002786584,0.11165172,0.67194235,0.000029323086,0.00015557824,0.00006396339,0.017065577],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507916,0.00062475906,0.00059335126,0.00029973168,0.00302551,0.00037751402],"domain_scores_gemma":[0.98522955,0.0037883949,0.00084711926,0.0002471819,0.0075599,0.0023277737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057653747,0.0016773695,0.002513623,0.0021361408,0.0026508323,0.0055783144,0.002866026,0.010525287,0.011810243],"category_scores_gemma":[0.017576868,0.00069306296,0.001713311,0.0019737508,0.002674233,0.0043697758,0.0012732132,0.012976059,0.0049906615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022583636,0.0000058255405,0.00003672208,0.00054224354,0.000013443893,0.00005938216,0.00004864305,0.000011480828,0.000030718722,0.0003035214,0.98568976,0.013235593],"study_design_scores_gemma":[0.00002388079,0.000015975478,0.00026150432,0.0013225557,0.000034753437,0.00011666266,0.00011221597,0.000020694852,0.000024805844,0.00043536507,0.99761957,0.0000118537755],"about_ca_topic_score_codex":0.08654541,"about_ca_topic_score_gemma":0.27855918,"teacher_disagreement_score":0.9134546,"about_ca_system_score_codex":0.012617676,"about_ca_system_score_gemma":0.03069792,"threshold_uncertainty_score":0.17208332},"labels":[],"label_agreement":null},{"id":"W3005838166","doi":"10.1080/17512433.2020.1730812","title":"A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review","year":2020,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Nova Scotia Health Authority; Dalhousie University","funders":"National Institute on Aging; Medical Research Council; National Health and Medical Research Council; Mitacs","keywords":"Deprescribing; Medicine; Psychological intervention; Polypharmacy; Health care; Intervention (counseling); Nursing; Intensive care medicine","score_opus":0.2942812299582992,"score_gpt":0.5958405295606356,"score_spread":0.3015592996023364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005838166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006041001,0.9936893,0.00064120296,0.002733255,0.00035153958,0.00034043507,0.0001850587,0.000008570601,0.0014465291],"genre_scores_gemma":[0.012222746,0.9825957,0.0023181993,0.0016904887,0.00017821323,0.0005960644,0.00013151966,0.000005433779,0.0002617038],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98982364,0.004829962,0.0029294055,0.0006561635,0.0015029296,0.00025795697],"domain_scores_gemma":[0.970827,0.021893105,0.0038106898,0.0005394984,0.0026632536,0.00026649493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014470187,0.0012107965,0.0024598283,0.00973701,0.00100144,0.00463203,0.0014870592,0.0020809823,0.0029766695],"category_scores_gemma":[0.04237088,0.00067455746,0.0034867679,0.009591067,0.0013063063,0.004581184,0.0027909228,0.0019706318,0.000412591],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010725829,0.00004484617,0.0015110086,0.7231235,0.002418183,0.0003643361,0.0035189544,0.00040365287,0.00027931435,0.013390151,0.012237045,0.24260172],"study_design_scores_gemma":[0.00003942246,0.000110492394,0.0019354782,0.849159,0.005657125,0.00054238754,0.0027477401,0.0001829098,0.00021654004,0.002531723,0.13683915,0.00003808881],"about_ca_topic_score_codex":0.0073598595,"about_ca_topic_score_gemma":0.019777656,"teacher_disagreement_score":0.014470187,"about_ca_system_score_codex":0.005246152,"about_ca_system_score_gemma":0.02327013,"threshold_uncertainty_score":0.07652658},"labels":[],"label_agreement":null},{"id":"W3016572994","doi":"10.1080/17512433.2020.1758063","title":"Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut","year":2020,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Gut flora; Dysbiosis; Bacteroides fragilis; Context (archaeology); Cancer; Biomarker; Fusobacterium nucleatum; Clinical trial; Disease; Immune system; Microbiome; Colorectal cancer; Immunology; Oncology; Bioinformatics; Internal medicine; Antibiotics; Biology; Periodontitis; Microbiology","score_opus":0.09264462083708122,"score_gpt":0.5159903345968604,"score_spread":0.42334571375977914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016572994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022219277,0.9963743,0.0000955036,0.002590982,0.0003650495,0.0000041516105,0.00006198574,0.0000040231225,0.00028177406],"genre_scores_gemma":[0.00290032,0.99521744,0.0001584027,0.00093963207,0.000499962,0.000008133482,0.0000436564,0.0000014568947,0.00023099784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999493,0.00019768058,0.00006572234,0.00008835774,0.000118743315,0.000036362646],"domain_scores_gemma":[0.9984869,0.00097080815,0.00020677979,0.000024525458,0.00026799747,0.00004297588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010093177,0.0005600247,0.0017770877,0.000827389,0.00015862397,0.00125411,0.0006415384,0.0015472539,0.0031612543],"category_scores_gemma":[0.0040507237,0.0001671622,0.0011625942,0.0010448163,0.0004515613,0.0010791431,0.0004434583,0.0016959099,0.00094145414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004219817,0.000066887595,0.0021888525,0.05825892,0.0011485638,0.00015223844,0.00010133358,0.00035092246,0.0009846163,0.0031346,0.040610474,0.89258057],"study_design_scores_gemma":[0.00021982494,0.0006036352,0.02168542,0.13832687,0.005388021,0.0025164064,0.000583456,0.0007757137,0.0011848414,0.01374022,0.8148245,0.00015102499],"about_ca_topic_score_codex":0.0017007831,"about_ca_topic_score_gemma":0.0024317687,"teacher_disagreement_score":0.0031612543,"about_ca_system_score_codex":0.00052952766,"about_ca_system_score_gemma":0.0013239281,"threshold_uncertainty_score":0.010575414},"labels":[],"label_agreement":null},{"id":"W3031742716","doi":"10.1080/17512433.2020.1772054","title":"Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments","year":2020,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Psychotherapist; Psilocybin; Perspective (graphical); Psychology; Hallucinogen; Psychopharmacology; Hypnosis; Psychopathology; MEDLINE; Neurochemical; Medicine; Psychiatry; Alternative medicine; Neuroscience","score_opus":0.19465118775830936,"score_gpt":0.5881763824918772,"score_spread":0.39352519473356784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031742716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000110854584,0.99668103,0.00021932866,0.0007140065,0.00034925382,0.00001792258,0.000020041083,0.000008883345,0.0018786261],"genre_scores_gemma":[0.0019558559,0.9952845,0.0005277664,0.00088085607,0.0004933905,0.00002647891,0.000037540452,0.0000030803944,0.00079054624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994648,0.00019712887,0.00007749921,0.00008262015,0.00013960851,0.0000383133],"domain_scores_gemma":[0.99944085,0.00033840386,0.00009173359,0.000018164992,0.00008647467,0.000024316396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083314255,0.00064728287,0.0010492872,0.0016792805,0.00024565577,0.0010935346,0.00072125683,0.001341266,0.008089669],"category_scores_gemma":[0.0014545503,0.00017568292,0.0010094657,0.0014250537,0.000530684,0.0011794762,0.00088965654,0.0018115676,0.001663647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008666991,0.000053510485,0.00009928172,0.044538002,0.00023645037,0.00008998658,0.000067099194,0.00016458797,0.00043370388,0.005969085,0.020406084,0.9278555],"study_design_scores_gemma":[0.00011632881,0.00018758331,0.001978233,0.067174695,0.00071575114,0.0025628745,0.00014728779,0.0002485293,0.00040243918,0.008837778,0.91759557,0.00003303964],"about_ca_topic_score_codex":0.00093997526,"about_ca_topic_score_gemma":0.002096168,"teacher_disagreement_score":0.008089669,"about_ca_system_score_codex":0.00089029415,"about_ca_system_score_gemma":0.0016545651,"threshold_uncertainty_score":0.027062595},"labels":[],"label_agreement":null},{"id":"W3094092946","doi":"10.1080/17512433.2020.1841633","title":"Managing blood disorders during the Covid-19 pandemic: current pharmacological insights","year":2020,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Disease; Intensive care medicine; Virology; Outbreak; Infectious disease (medical specialty); Pathology","score_opus":0.23019505128730655,"score_gpt":0.5858739940751676,"score_spread":0.35567894278786105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094092946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023762326,0.9797943,0.00029330805,0.016580703,0.0009669558,0.000012479776,0.000032395954,0.000014807316,0.0020674642],"genre_scores_gemma":[0.0022911343,0.98643386,0.0006131554,0.00750197,0.0025502304,0.000015160378,0.000035763824,0.000004628856,0.0005540892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990402,0.00033880005,0.0001441881,0.000113231545,0.00027376608,0.000089705165],"domain_scores_gemma":[0.99542624,0.0025105672,0.0005632616,0.00008497239,0.0011662325,0.00024867442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027186999,0.00041223795,0.0013638753,0.0008895781,0.00034420646,0.0022465012,0.0008598579,0.002144511,0.0032933205],"category_scores_gemma":[0.005779712,0.00019998543,0.0008395643,0.0006548988,0.00090538437,0.002293994,0.00086140743,0.0043148664,0.0016926515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026542266,0.0001548882,0.00043481623,0.011635832,0.0002224332,0.00016468874,0.00013490947,0.0002734973,0.000918574,0.0065387725,0.08678978,0.89246637],"study_design_scores_gemma":[0.0002084275,0.00047068513,0.0014730776,0.020171331,0.0003369402,0.0012314045,0.00025140264,0.0002639433,0.00052866177,0.008435942,0.96657807,0.00005018176],"about_ca_topic_score_codex":0.0010568439,"about_ca_topic_score_gemma":0.0034850421,"teacher_disagreement_score":0.0032933205,"about_ca_system_score_codex":0.00071820704,"about_ca_system_score_gemma":0.0017007403,"threshold_uncertainty_score":0.014378071},"labels":[],"label_agreement":null},{"id":"W3111582504","doi":"10.1080/17512433.2021.1863784","title":"Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-art","year":2020,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Eicosapentaenoic acid; Docosahexaenoic acid; Hypertriglyceridemia; Polyunsaturated fatty acid; Medicine; Fish oil; Pharmacology; Omega 3 fatty acid; Internal medicine; Fatty acid; Biochemistry; Chemistry; Biology; Cholesterol; Triglyceride","score_opus":0.0842247830639177,"score_gpt":0.4799734632208405,"score_spread":0.39574868015692277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111582504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077501994,0.99901474,0.000049125756,0.00048729332,0.0001764044,0.0000036725041,0.000013948024,0.0000029789785,0.0001743238],"genre_scores_gemma":[0.000384355,0.9990532,0.00008224117,0.00020834884,0.00018498141,0.0000042278907,0.000016070182,8.464544e-7,0.000065695305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942267,0.00009789923,0.00016141347,0.00011548525,0.00016671464,0.0000358666],"domain_scores_gemma":[0.9972385,0.0017621567,0.0003579062,0.000037454614,0.0005163266,0.000087600856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016610657,0.0008337064,0.0018351078,0.0030816537,0.00033651973,0.001260454,0.0010267064,0.0013811443,0.0032907892],"category_scores_gemma":[0.0028121448,0.00034448845,0.0013326951,0.0028673345,0.0005132175,0.0016437608,0.000750516,0.0019388602,0.0010772619],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020610142,0.00010699838,0.000749235,0.07377131,0.00041191577,0.00015712796,0.00012170588,0.00023269893,0.00081956515,0.0017750838,0.020742217,0.900906],"study_design_scores_gemma":[0.00008432157,0.0004607695,0.0055578863,0.08984913,0.0023707948,0.0019735533,0.00041322835,0.00030728488,0.0007151111,0.0038430453,0.8943448,0.00008002676],"about_ca_topic_score_codex":0.0016311216,"about_ca_topic_score_gemma":0.002222453,"teacher_disagreement_score":0.0032907892,"about_ca_system_score_codex":0.00058363855,"about_ca_system_score_gemma":0.0018689131,"threshold_uncertainty_score":0.011008859},"labels":[],"label_agreement":null},{"id":"W3117036619","doi":"10.1080/17512433.2021.1865798","title":"Reliance: a smarter way of regulating medical products - The IPRP survey","year":2020,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Quality (philosophy); Regulatory authority; Product (mathematics); Business; Regulatory science; Medicine; Public relations; Public administration; Political science","score_opus":0.17774188390405873,"score_gpt":0.5192638689955099,"score_spread":0.34152198509145115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117036619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8051916,0.012329613,0.013513965,0.11085556,0.00066385104,0.0008548243,0.0020907125,0.00015971689,0.054340255],"genre_scores_gemma":[0.96111876,0.007384742,0.0034767194,0.02288495,0.00030165698,0.00041485234,0.0004290668,0.00005668583,0.0039325575],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9562031,0.0267068,0.0032562173,0.0018872977,0.010073111,0.0018734637],"domain_scores_gemma":[0.91371924,0.048946667,0.018425781,0.0033168702,0.0122028105,0.0033885883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036198422,0.0001685804,0.00034554643,0.001566146,0.0013838547,0.0037994285,0.0008028249,0.0019080036,0.004067135],"category_scores_gemma":[0.08402015,0.00034184355,0.00039195226,0.0019428659,0.0030409633,0.005971153,0.0040093926,0.004619687,0.0008244979],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018758705,0.0002706346,0.27974722,0.004836665,0.00013101108,0.0015032153,0.28463873,0.000640852,0.0030898822,0.026578808,0.10247178,0.29590374],"study_design_scores_gemma":[0.000016491218,0.00047818167,0.23517092,0.0034783212,0.000046165052,0.0035430188,0.23821226,0.0008621034,0.0013161658,0.0036053522,0.51309705,0.00017399329],"about_ca_topic_score_codex":0.0030015237,"about_ca_topic_score_gemma":0.002572677,"teacher_disagreement_score":0.036198422,"about_ca_system_score_codex":0.0028315843,"about_ca_system_score_gemma":0.004285973,"threshold_uncertainty_score":0.19143784},"labels":[],"label_agreement":null},{"id":"W3207599934","doi":"10.1080/17512433.2022.1987883","title":"Comparison of the registration process of the medicines control authority of Zimbabwe with Australia, Canada, Singapore, and Switzerland: benchmarking best practices","year":2021,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bill and Melinda Gates Foundation","keywords":"Benchmarking; Medicine; Best practice; Control (management); Process (computing); Optometry; Management; Marketing; Business","score_opus":0.23367907985036063,"score_gpt":0.5807938342554807,"score_spread":0.3471147544051201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207599934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.878174,0.017859306,0.009695122,0.013956429,0.00027852153,0.00706488,0.0028715015,0.00032251814,0.069777586],"genre_scores_gemma":[0.9874594,0.002534262,0.006226295,0.00039471444,0.000028523405,0.0005677574,0.000721994,0.000032293152,0.002034708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.92456573,0.03932026,0.009085704,0.0028559822,0.01980665,0.0043657185],"domain_scores_gemma":[0.8613113,0.038572438,0.031594057,0.00648938,0.0547937,0.007239153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06081706,0.00030873576,0.00041605005,0.0060229655,0.0026379705,0.004817478,0.0010325428,0.00052444387,0.0019779566],"category_scores_gemma":[0.122653276,0.00031492667,0.00055648154,0.0069080996,0.0014523807,0.0018062724,0.0028006206,0.0006932103,0.00034192178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014265721,0.00028026433,0.54305416,0.0058992393,0.00054550794,0.0008234419,0.04486507,0.0033706457,0.0071700816,0.013731409,0.014988774,0.36384475],"study_design_scores_gemma":[0.00015726314,0.00066421495,0.89136493,0.0020248245,0.00022542788,0.0004905649,0.018560925,0.002796064,0.004476705,0.0007755734,0.07830363,0.00015987334],"about_ca_topic_score_codex":0.32622498,"about_ca_topic_score_gemma":0.37081534,"teacher_disagreement_score":0.673775,"about_ca_system_score_codex":0.020736368,"about_ca_system_score_gemma":0.08548114,"threshold_uncertainty_score":0.6486523},"labels":[],"label_agreement":null},{"id":"W4200402274","doi":"10.1080/17512433.2022.2017771","title":"UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions","year":2021,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cannabis; Chronic pain; Brief Pain Inventory; Visual analogue scale; Nausea; Adverse effect; Cannabidiol; Quality of life (healthcare); McGill Pain Questionnaire; Physical therapy; Internal medicine; Psychiatry","score_opus":0.09424217047519787,"score_gpt":0.5619543234154374,"score_spread":0.4677121529402395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200402274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704957,0.0007383994,0.0000784693,0.000028090259,0.0000057813936,0.00004474612,0.001694242,0.0000050344047,0.0003554801],"genre_scores_gemma":[0.9978346,0.00020780358,0.00009769997,0.000015272195,0.0000092496275,0.000033306937,0.0016864139,0.0000031246132,0.000112408445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746084,0.00078806095,0.00045968685,0.00037275988,0.00067457464,0.00024405963],"domain_scores_gemma":[0.99220216,0.0011275726,0.0050537745,0.00048335476,0.00070389634,0.0004292815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013127077,0.00021433587,0.0006107169,0.0021597964,0.0003601606,0.0006683335,0.0004528938,0.0004416784,0.0019601935],"category_scores_gemma":[0.00586406,0.00025149446,0.0004515133,0.0032335464,0.00033894973,0.0006067184,0.0010531398,0.00031056404,0.00038100214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035739085,0.000024017038,0.99719477,0.00005081154,0.000067183464,0.00014389925,0.00006537218,0.000027796927,0.00014834708,0.000012721968,0.00014622293,0.0017613671],"study_design_scores_gemma":[0.000019652069,0.000107023756,0.99874973,0.000018699973,0.00003622454,0.00051824056,0.000097788725,0.000112917216,0.000055169126,0.0000047044887,0.00027470523,0.000005207255],"about_ca_topic_score_codex":0.007887767,"about_ca_topic_score_gemma":0.0076576266,"teacher_disagreement_score":0.007887767,"about_ca_system_score_codex":0.000688217,"about_ca_system_score_gemma":0.0006798672,"threshold_uncertainty_score":0.01568371},"labels":[],"label_agreement":null},{"id":"W4220821209","doi":"10.1080/17512433.2022.2054413","title":"Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause","year":2022,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Drospirenone; Menopause; Tolerability; Estrogen; Estrogen receptor; Breast cancer; Internal medicine; Pharmacology; Oncology; Endocrinology; Cancer; Adverse effect","score_opus":0.04527136181481349,"score_gpt":0.45804086161140084,"score_spread":0.41276949979658734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220821209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021983456,0.9956995,0.00016697757,0.0007103913,0.00031270995,0.000012259563,0.00007385203,0.000009502764,0.0027950604],"genre_scores_gemma":[0.0015983643,0.9954501,0.00021056057,0.00065691135,0.00030702335,0.000016197666,0.00009738594,0.0000027697624,0.0016607802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987555,0.000024659643,0.000014242604,0.0000241938,0.00005051566,0.0000109047505],"domain_scores_gemma":[0.99984145,0.00007185492,0.000026373466,0.0000032938124,0.00004575241,0.000011285326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033545741,0.00045207207,0.00073366304,0.0011602008,0.00015264093,0.0006543947,0.000525548,0.000746376,0.007164159],"category_scores_gemma":[0.0005059854,0.00014577816,0.00040143455,0.000775097,0.00019243326,0.00058373896,0.00032599975,0.0013254352,0.0029599245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011502699,0.00004877177,0.00011266144,0.016743146,0.0000883553,0.00021619826,0.00004664828,0.00025428747,0.0026646394,0.0039326306,0.03855047,0.9372272],"study_design_scores_gemma":[0.00004150899,0.00015814746,0.0005534294,0.003308177,0.000107936205,0.0013721345,0.00003455759,0.00008729836,0.00057634915,0.0011359726,0.9926109,0.000013556767],"about_ca_topic_score_codex":0.0005909103,"about_ca_topic_score_gemma":0.0013172895,"teacher_disagreement_score":0.007164159,"about_ca_system_score_codex":0.00031973477,"about_ca_system_score_gemma":0.00057877594,"threshold_uncertainty_score":0.023966491},"labels":[],"label_agreement":null},{"id":"W4224310469","doi":"10.1080/17512433.2022.2070473","title":"Pharmacological profile of once-weekly injectable semaglutide for chronic weight management","year":2022,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Novo Nordisk; National Institute for Health and Care Research","keywords":"Semaglutide; Medicine; Tolerability; Weight loss; Overweight; Weight management; Obesity; Pharmacology; Type 2 diabetes; Diabetes mellitus; Internal medicine; Liraglutide; Adverse effect; Endocrinology","score_opus":0.06276375467588204,"score_gpt":0.46045669976235126,"score_spread":0.39769294508646924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224310469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008408007,0.9547214,0.0042787534,0.011631124,0.0016591802,0.00012604435,0.000620108,0.00013967468,0.018415816],"genre_scores_gemma":[0.07546599,0.88928825,0.004659903,0.013806488,0.0031823418,0.00018580652,0.0009998253,0.00004079464,0.0123705445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997482,0.000077124016,0.000025273102,0.000035901074,0.00009300306,0.000020622781],"domain_scores_gemma":[0.99967897,0.00010567224,0.00009104948,0.000007802612,0.00009522532,0.00002135873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058903673,0.00026226434,0.0005726019,0.0003439447,0.00009240659,0.0006355624,0.0003685468,0.00079288165,0.005544367],"category_scores_gemma":[0.0007375315,0.00008470355,0.000483082,0.00026174274,0.00023299652,0.00044848677,0.00019440491,0.0013343226,0.0023038655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010336317,0.00016252621,0.0006034643,0.009534066,0.00018226911,0.0004770134,0.00005778758,0.00054880016,0.014575307,0.0028044127,0.06211593,0.90790486],"study_design_scores_gemma":[0.0007805451,0.0026134453,0.0046129837,0.0054732673,0.00042836697,0.0048577436,0.000100518126,0.0010755484,0.008407683,0.0030566559,0.96852374,0.00006938572],"about_ca_topic_score_codex":0.00049844774,"about_ca_topic_score_gemma":0.0010004201,"teacher_disagreement_score":0.005544367,"about_ca_system_score_codex":0.00029433882,"about_ca_system_score_gemma":0.0003267428,"threshold_uncertainty_score":0.018547773},"labels":[],"label_agreement":null},{"id":"W4283641162","doi":"10.1080/17512433.2022.2094768","title":"Safety and efficacy of therapies for chylomicronemia","year":2022,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Hypertriglyceridemia; Acute pancreatitis; Chylomicron; Pancreatitis; Apolipoprotein B; Pharmacology; Bioinformatics; Internal medicine; Triglyceride; Cholesterol; Lipoprotein; Very low-density lipoprotein; Biology","score_opus":0.05282777732241084,"score_gpt":0.4729195015658429,"score_spread":0.42009172424343205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283641162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17231013,0.7667109,0.0043899757,0.012670106,0.0020588748,0.00068030047,0.0050618625,0.00022908533,0.035888903],"genre_scores_gemma":[0.8132807,0.16096686,0.002627016,0.010082764,0.0026781398,0.0009842388,0.0034670066,0.00005993364,0.0058533307],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99880576,0.0005661442,0.00014004901,0.00015458389,0.0002589645,0.00007449305],"domain_scores_gemma":[0.9972717,0.001275922,0.00086742966,0.00010967225,0.00030244683,0.0001728506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017259588,0.00023893868,0.00095595955,0.00022202713,0.00015537182,0.00060883764,0.0003285752,0.00078981364,0.0062160143],"category_scores_gemma":[0.003980383,0.00005087445,0.0011797845,0.0002576802,0.00024256979,0.00038444652,0.00022047388,0.0014857606,0.001111532],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040206507,0.00071655156,0.0055030133,0.0106804,0.0025213824,0.00027606505,0.00008747301,0.0007853906,0.00596238,0.0020795246,0.021027751,0.9101535],"study_design_scores_gemma":[0.055495616,0.16456485,0.18475357,0.025787124,0.015237389,0.008916652,0.0007899964,0.004986666,0.023884209,0.0156894,0.49964306,0.00025148148],"about_ca_topic_score_codex":0.00016983986,"about_ca_topic_score_gemma":0.00030428095,"teacher_disagreement_score":0.0062160143,"about_ca_system_score_codex":0.00047223194,"about_ca_system_score_gemma":0.00045082453,"threshold_uncertainty_score":0.02079463},"labels":[],"label_agreement":null},{"id":"W4283713772","doi":"10.1080/17512433.2022.2092470","title":"Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis","year":2022,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Medicine; Calcineurin; Lupus nephritis; Pharmacodynamics; Pharmacology; Pharmacokinetics; Drug; Mycophenolate; Mycophenolic acid; Proteinuria; Clinical trial; Internal medicine; Kidney; Transplantation; Disease","score_opus":0.2687197206563499,"score_gpt":0.5653869755982474,"score_spread":0.29666725494189744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283713772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021962373,0.9983789,0.0001010258,0.0002029859,0.00012691334,0.000007747982,0.000023198714,0.00000682402,0.0009327588],"genre_scores_gemma":[0.0019049243,0.996756,0.00020206772,0.00028427772,0.00014890562,0.000008884266,0.00005089377,0.000001661544,0.0006424137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984133,0.000026601258,0.000022191385,0.000029302659,0.000068640395,0.000011919054],"domain_scores_gemma":[0.99984336,0.00007009461,0.000038167756,0.0000034120637,0.00003294172,0.000012074192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002777398,0.000466552,0.0007721948,0.0019280979,0.0002032672,0.0006162648,0.00042360078,0.0006075245,0.0038958609],"category_scores_gemma":[0.00044588905,0.00012744148,0.00046956004,0.0014360907,0.00022047726,0.00056616025,0.0003600195,0.0011131858,0.0013064613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001054321,0.000079548205,0.00015026049,0.02866794,0.00017171944,0.00021618865,0.000047895694,0.00023293984,0.0026496402,0.0017040276,0.0218293,0.9441451],"study_design_scores_gemma":[0.000083499675,0.00021626383,0.0012989674,0.008033279,0.0004136537,0.002912726,0.000046234654,0.00016172162,0.001279989,0.0011499402,0.98438025,0.000023501838],"about_ca_topic_score_codex":0.0007600533,"about_ca_topic_score_gemma":0.0016001528,"teacher_disagreement_score":0.0038958609,"about_ca_system_score_codex":0.00030242163,"about_ca_system_score_gemma":0.0006773559,"threshold_uncertainty_score":0.013032913},"labels":[],"label_agreement":null},{"id":"W4292448866","doi":"10.1080/17512433.2022.2088503","title":"Reliance is key to effective access and oversight of medical products in case of public health emergencies","year":2022,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Key (lock); Public health; Quality (philosophy); Business; Authorization; Medicine; Risk analysis (engineering); Pandemic; Coronavirus disease 2019 (COVID-19); Public relations; Computer security; Computer science; Political science","score_opus":0.3233802500915234,"score_gpt":0.6163913624562355,"score_spread":0.2930111123647121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292448866","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0411389,0.061041873,0.11530746,0.38999635,0.0047172187,0.0010608545,0.000493667,0.0010798089,0.3851639],"genre_scores_gemma":[0.7691192,0.052916978,0.054208744,0.088110775,0.006013854,0.000704556,0.00044827527,0.00035356524,0.028123977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.90939194,0.033074707,0.006003197,0.0047654794,0.043221936,0.0035427222],"domain_scores_gemma":[0.83252865,0.07184008,0.035838824,0.012971033,0.04190135,0.004920069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06211133,0.00045873842,0.0008578659,0.0017730243,0.0024467213,0.009935884,0.0031002199,0.005708567,0.00951753],"category_scores_gemma":[0.11278196,0.0005137927,0.00088522065,0.0017104775,0.0083006015,0.007872326,0.0060036783,0.0077336095,0.0030592096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019416618,0.00026100755,0.013013711,0.004379299,0.0001887783,0.0009860741,0.0063616596,0.0017786315,0.0073870765,0.28163478,0.091999784,0.591815],"study_design_scores_gemma":[0.00005105083,0.0004330399,0.0106921345,0.005812833,0.0001215214,0.0018090409,0.002664905,0.0008973155,0.004888386,0.07926667,0.89322895,0.00013422898],"about_ca_topic_score_codex":0.00293847,"about_ca_topic_score_gemma":0.0032635662,"teacher_disagreement_score":0.06211133,"about_ca_system_score_codex":0.004720398,"about_ca_system_score_gemma":0.02540653,"threshold_uncertainty_score":0.32848006},"labels":[],"label_agreement":null},{"id":"W4387840848","doi":"10.1080/17512433.2023.2274538","title":"A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia","year":2023,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Ottawa; McMaster University; University of Toronto","funders":"","keywords":"Amisulpride; Medicine; Schizophrenia (object-oriented programming); Bipolar disorder; Narrative review; Depressive symptoms; Psychiatry; Major depressive disorder; Aripiprazole; Treatment of bipolar disorder; Internal medicine; Antipsychotic; Lithium (medication); Cognition","score_opus":0.14904308174160405,"score_gpt":0.5336761911223976,"score_spread":0.38463310938079354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387840848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011037154,0.9977442,0.00006696792,0.00061727205,0.00022744363,0.00002243994,0.000092655595,0.0000047993713,0.001113906],"genre_scores_gemma":[0.0007941173,0.997459,0.00012624945,0.00082628266,0.00024392304,0.0000307585,0.00008848903,0.0000015418755,0.0004296689],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996414,0.00008455494,0.000098169,0.00005833848,0.000097356104,0.00002008053],"domain_scores_gemma":[0.9989967,0.00059419166,0.0002260134,0.000012173309,0.0001374143,0.000033490476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000741824,0.0005929416,0.0013908605,0.0020544787,0.00022242652,0.0009154145,0.0009061577,0.0010159536,0.011074959],"category_scores_gemma":[0.00232973,0.00020511364,0.0011307363,0.0018398514,0.00029543135,0.0009438405,0.00047837614,0.0009914223,0.0015577095],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015632111,0.00003502041,0.00017294212,0.25396022,0.00034763745,0.00028334657,0.00014480729,0.00022226803,0.00075256365,0.002849318,0.07699827,0.6640773],"study_design_scores_gemma":[0.00008708591,0.00016936936,0.0014395353,0.13748048,0.0010843285,0.001470782,0.000119130906,0.000094849725,0.00019811334,0.0011360343,0.85669583,0.000024402554],"about_ca_topic_score_codex":0.0017630266,"about_ca_topic_score_gemma":0.0040658894,"teacher_disagreement_score":0.011074959,"about_ca_system_score_codex":0.00072097307,"about_ca_system_score_gemma":0.0018229098,"threshold_uncertainty_score":0.037049413},"labels":[],"label_agreement":null},{"id":"W4387965390","doi":"10.1080/17512433.2023.2276309","title":"Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspective","year":2023,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cannabis; Medicine; Addiction; Psychiatry; Intervention (counseling); Perspective (graphical); Posttraumatic stress; Psychotherapist; Psychology","score_opus":0.3532513076443655,"score_gpt":0.5980582301905207,"score_spread":0.24480692254615521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387965390","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004080988,0.89631313,0.0005989989,0.09678081,0.0025345366,0.000029128703,0.000026380492,0.00001855089,0.0032903275],"genre_scores_gemma":[0.0036875186,0.96450937,0.0017210288,0.025800714,0.0025579713,0.00004317692,0.000024650271,0.000006364698,0.0016492611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756277,0.0010136784,0.00041641603,0.00019026482,0.0006851183,0.00013178302],"domain_scores_gemma":[0.99380517,0.0031493697,0.0005994474,0.00011485705,0.001965501,0.00036557653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006562692,0.00050016184,0.0017683458,0.0013034336,0.0009541929,0.0026720173,0.0016441332,0.0059923804,0.0053244065],"category_scores_gemma":[0.010401911,0.0003445632,0.0011204926,0.0010995504,0.0016984676,0.0046652844,0.0019214427,0.007848545,0.0019519243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015469921,0.00012954677,0.0005105014,0.0316434,0.00012851143,0.0017182059,0.0013594091,0.00039121474,0.0010636637,0.012149489,0.13187511,0.8188762],"study_design_scores_gemma":[0.00006514059,0.00019356061,0.0012260329,0.030329052,0.00014519627,0.004596032,0.0017751079,0.00019618563,0.00026209262,0.010468993,0.95068085,0.00006183318],"about_ca_topic_score_codex":0.0062817647,"about_ca_topic_score_gemma":0.016294764,"teacher_disagreement_score":0.006562692,"about_ca_system_score_codex":0.001492708,"about_ca_system_score_gemma":0.008566787,"threshold_uncertainty_score":0.03470725},"labels":[],"label_agreement":null},{"id":"W4389144356","doi":"10.1080/17512433.2023.2289543","title":"Novel insights into molecular and cellular aspects of delayed drug hypersensitivity reactions","year":2023,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; MEDLINE; Intensive care medicine; Drug development; Bioinformatics; Drug; Pharmacology","score_opus":0.12034599111117852,"score_gpt":0.4958279899350887,"score_spread":0.3754819988239102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389144356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020667419,0.9977276,0.00019520754,0.00042596646,0.00022792796,0.000007024064,0.000030448182,0.0000052076393,0.00117404],"genre_scores_gemma":[0.0025292386,0.9960796,0.00021591719,0.0003623024,0.00023518642,0.000008821471,0.00003962232,0.0000011746391,0.0005281082],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997695,0.000053446063,0.000030915813,0.000039029997,0.00007896609,0.000028141973],"domain_scores_gemma":[0.99960464,0.00017476741,0.000080365295,0.000010563178,0.00010965301,0.000020155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005471829,0.0006504733,0.0011146517,0.0015739009,0.00020354589,0.001231821,0.00062040635,0.0010336323,0.006224931],"category_scores_gemma":[0.000762437,0.00017661964,0.00085472385,0.0012704234,0.00042275424,0.001314508,0.0005107591,0.001585636,0.0014280847],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028269866,0.00013049837,0.00040533507,0.0974306,0.00030248507,0.00091012026,0.00023253026,0.0005418445,0.011877719,0.014515427,0.02922047,0.8441503],"study_design_scores_gemma":[0.000066191285,0.00028776543,0.0023183026,0.019552343,0.0005304406,0.00436383,0.00023319184,0.00023817629,0.0032538746,0.0077166623,0.9613957,0.00004362823],"about_ca_topic_score_codex":0.0005487867,"about_ca_topic_score_gemma":0.0009693293,"teacher_disagreement_score":0.006224931,"about_ca_system_score_codex":0.0005142427,"about_ca_system_score_gemma":0.0011496997,"threshold_uncertainty_score":0.020824492},"labels":[],"label_agreement":null},{"id":"W4391384708","doi":"10.1080/17512433.2024.2313616","title":"The effect of different levothyroxine administration regimens on thyroid hormone levels: a systematic review, pairwise, and network meta-analysis","year":2024,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Meta-analysis; Randomized controlled trial; Internal medicine; Levothyroxine; Confidence interval; Relative risk; Regimen; Publication bias; Thyroid","score_opus":0.13927712497230965,"score_gpt":0.5109321245402111,"score_spread":0.37165499956790143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391384708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003502659,0.9922536,0.0015637255,0.00029006702,0.00030428523,0.00083222066,0.00080971577,0.00003403956,0.00040970035],"genre_scores_gemma":[0.25828326,0.720545,0.009865489,0.0019870552,0.0006178969,0.00653165,0.0014949491,0.0000762396,0.00059843494],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9582502,0.02489478,0.009892059,0.0030497708,0.0033277667,0.0005852961],"domain_scores_gemma":[0.9372629,0.052071407,0.006839579,0.0014179947,0.0021178077,0.00029030823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036807418,0.004052565,0.023671448,0.008207919,0.00082456734,0.004965196,0.0025107695,0.0024199306,0.005569595],"category_scores_gemma":[0.09464366,0.0017862142,0.046684515,0.007475874,0.001270349,0.0030372054,0.0022525825,0.0022710012,0.00042591806],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001441027,0.000017781567,0.0018375495,0.36851507,0.6187372,0.00006662205,0.00006241116,0.00041226821,0.00010528727,0.00017430466,0.00029339685,0.008337047],"study_design_scores_gemma":[0.00078785385,0.00019325195,0.0015270637,0.03036047,0.9650743,0.000058847978,0.00003222356,0.00020047018,0.00008855452,0.0004252038,0.0012307417,0.000021114516],"about_ca_topic_score_codex":0.005757991,"about_ca_topic_score_gemma":0.012141615,"teacher_disagreement_score":0.036807418,"about_ca_system_score_codex":0.0039630756,"about_ca_system_score_gemma":0.004363596,"threshold_uncertainty_score":0.19465858},"labels":[],"label_agreement":null},{"id":"W4392473314","doi":"10.1080/17512433.2024.2318465","title":"Exposure–efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn’s disease and ulcerative colitis","year":2024,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Crohn's disease; Disease; Colitis; Internal medicine; Inflammatory bowel disease; Gastroenterology","score_opus":0.03366104209284545,"score_gpt":0.41024959415369133,"score_spread":0.3765885520608459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392473314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547523,0.0018361766,0.0015337866,0.000052910338,0.0000059465515,0.00005296163,0.00019032205,0.000015326847,0.00083730766],"genre_scores_gemma":[0.9991642,0.0001436553,0.00035295336,0.000014210027,0.0000059589765,0.000023031806,0.00014969776,0.0000040331142,0.00014226143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751246,0.0015531325,0.00016599405,0.00026998614,0.00033169676,0.00016676933],"domain_scores_gemma":[0.9882996,0.00887227,0.0019097145,0.00045028148,0.0002667976,0.00020123157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051643075,0.00023380188,0.00060175767,0.00031257258,0.00009584835,0.0004920503,0.0001754601,0.00025832318,0.001400693],"category_scores_gemma":[0.009754534,0.00022161852,0.0009606141,0.00026322628,0.00021791727,0.00040799665,0.00030848244,0.00064845977,0.00012245007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08582098,0.001324236,0.6891837,0.0006806845,0.0044960715,0.00034840178,0.00040170577,0.024446703,0.024048954,0.0006418257,0.0006732373,0.16793348],"study_design_scores_gemma":[0.0014223811,0.041678205,0.90691215,0.00007043208,0.00255083,0.00112842,0.00013797692,0.03110543,0.010619826,0.000880009,0.0034477627,0.000046598067],"about_ca_topic_score_codex":0.00044313015,"about_ca_topic_score_gemma":0.00040448285,"teacher_disagreement_score":0.0051643075,"about_ca_system_score_codex":0.00044386703,"about_ca_system_score_gemma":0.0003248543,"threshold_uncertainty_score":0.027311802},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4394814052","doi":"10.1080/17512433.2024.2343913","title":"Engaging patients in conversations about deprescribing","year":2024,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; University of Ottawa; University of Waterloo","funders":"","keywords":"Deprescribing; Medicine; Polypharmacy; Intensive care medicine","score_opus":0.15684917259830164,"score_gpt":0.5650808202575986,"score_spread":0.408231647659297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394814052","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047038662,0.014729423,0.00013873681,0.09148994,0.8910407,0.00005098986,0.000049115286,0.000077377816,0.0023765748],"genre_scores_gemma":[0.0007393112,0.018406052,0.00023565939,0.083924346,0.88933927,0.00009005374,0.000042514286,0.00005998524,0.0071628424],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9857255,0.0053682653,0.0015789394,0.00084004033,0.0058663986,0.0006207244],"domain_scores_gemma":[0.9302188,0.044887323,0.0029164746,0.00094667997,0.015492669,0.005538097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0153548485,0.0031197146,0.002888901,0.002650696,0.0039743925,0.008818574,0.004723325,0.020327995,0.016343975],"category_scores_gemma":[0.074744284,0.0012780264,0.0030366352,0.0013983039,0.0037347102,0.006327204,0.0026163007,0.02704096,0.010551539],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029383402,0.000011515862,0.000014134147,0.00053518557,0.000020813788,0.00005377136,0.00006469372,0.000009943857,0.000027076332,0.00022768932,0.9913412,0.0076646474],"study_design_scores_gemma":[0.0001412954,0.0000834031,0.00021424172,0.0025955867,0.0001021767,0.00026236955,0.00021908611,0.00007314409,0.000104211336,0.0008063837,0.995368,0.000030154819],"about_ca_topic_score_codex":0.0020176817,"about_ca_topic_score_gemma":0.006315337,"teacher_disagreement_score":0.020327995,"about_ca_system_score_codex":0.0040029217,"about_ca_system_score_gemma":0.0058453507,"threshold_uncertainty_score":0.08120513},"labels":[],"label_agreement":null},{"id":"W4396854990","doi":"10.1080/17512433.2024.2355270","title":"Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks","year":2024,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Alberta Health; Alberta Health Services; Bruyère; University of Ottawa; University of British Columbia; University of Calgary; McGill University Health Centre","funders":"Health Canada","keywords":"Polypharmacy; Deprescribing; Medicine; Intensive care medicine; Medical emergency","score_opus":0.3037696699159056,"score_gpt":0.5820265566205958,"score_spread":0.2782568867046902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396854990","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0711027,0.34119898,0.0070951185,0.43635046,0.0042531006,0.000648593,0.00083886366,0.00017370672,0.13833848],"genre_scores_gemma":[0.55085593,0.3747626,0.011551586,0.049300857,0.0034850936,0.00058041903,0.0005974402,0.00010160605,0.008764558],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9919084,0.005182434,0.00039833132,0.00036463773,0.0015176202,0.0006285276],"domain_scores_gemma":[0.96960056,0.015745502,0.005172793,0.0008486976,0.0043314607,0.0043009757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011733177,0.0002862959,0.0004420916,0.0009774389,0.0010590436,0.0036126615,0.0010091686,0.0012478135,0.011213351],"category_scores_gemma":[0.03149186,0.00012775407,0.00079908734,0.0013499574,0.0011548888,0.003217634,0.003126144,0.0026522018,0.000719653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022372298,0.00033024375,0.015036956,0.007204889,0.00030682364,0.0001991428,0.0017097408,0.00056681427,0.0003128394,0.027640546,0.05091668,0.8955516],"study_design_scores_gemma":[0.00030109382,0.0016696538,0.074377134,0.039327286,0.001009236,0.0011319973,0.006738004,0.0015187939,0.0015530017,0.021828426,0.8504479,0.000097424745],"about_ca_topic_score_codex":0.0050375666,"about_ca_topic_score_gemma":0.009986799,"teacher_disagreement_score":0.011733177,"about_ca_system_score_codex":0.0028007913,"about_ca_system_score_gemma":0.008518001,"threshold_uncertainty_score":0.062051713},"labels":[],"label_agreement":null},{"id":"W4398256177","doi":"10.1080/17512433.2024.2359955","title":"The effect of anticholinergic drugs on cognition of patients with Parkinson’s disease: a cohort study from the Egyptian population","year":2024,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anticholinergic; Cognition; Disease; Parkinson's disease; Cohort; Anticholinergic agents; Population; Internal medicine; Psychiatry","score_opus":0.020087537303987726,"score_gpt":0.41689132635952963,"score_spread":0.3968037890555419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398256177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995639,0.00010694656,0.0000200874,0.000014280661,0.000002651379,0.000008658438,0.00012688294,7.781373e-7,0.00015586044],"genre_scores_gemma":[0.99942786,0.000123976,0.000035198125,0.000027783,0.000009027908,0.000009763108,0.00022313296,9.801371e-7,0.00014223668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997216,0.00004321672,0.00003356455,0.00007506456,0.000060682913,0.00006583858],"domain_scores_gemma":[0.9995764,0.000049260747,0.00013731085,0.000044535343,0.00008068094,0.00011185374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037381612,0.00040174177,0.00046615192,0.000895039,0.0008039672,0.00064965175,0.00028338417,0.00045308378,0.0013659865],"category_scores_gemma":[0.0008249658,0.00041583017,0.0004765472,0.0009237407,0.00023987753,0.00049384596,0.00040277847,0.0004933665,0.00025422886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011597812,0.00005846564,0.9985001,0.0000068940785,0.000044126456,0.00021445418,0.00015898824,0.000007894164,0.00014864799,0.000006675372,0.000049820286,0.000687859],"study_design_scores_gemma":[0.000010841144,0.0001788783,0.99872416,0.0000040079162,0.000030864347,0.00050773716,0.00032690138,0.00004088659,0.000023332406,0.0000085707525,0.00014062227,0.0000031540803],"about_ca_topic_score_codex":0.007443714,"about_ca_topic_score_gemma":0.008177968,"teacher_disagreement_score":0.007443714,"about_ca_system_score_codex":0.00029335468,"about_ca_system_score_gemma":0.0003206145,"threshold_uncertainty_score":0.014800787},"labels":[],"label_agreement":null},{"id":"W4400953751","doi":"10.1080/17512433.2024.2375449","title":"Somatic pharmacogenomics in the treatment prognosis of locally advanced rectal cancer patients: a narrative review of the literature","year":2024,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute","keywords":"Medicine; Pharmacogenomics; Colorectal cancer; Narrative review; Somatic cell; Oncology; Internal medicine; Intensive care medicine; Cancer; Pharmacology","score_opus":0.07208242355327657,"score_gpt":0.5248407174794154,"score_spread":0.45275829392613887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400953751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011769058,0.99932265,0.000031636562,0.00017781208,0.000047649803,0.000004493489,0.00004027659,0.0000022140996,0.00025557657],"genre_scores_gemma":[0.0010027618,0.9985892,0.00007755658,0.00014156867,0.00007304426,0.0000061315836,0.000034730103,5.9880125e-7,0.000074292395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997241,0.000062349616,0.00007810562,0.000050777893,0.00006884573,0.000015872707],"domain_scores_gemma":[0.99867576,0.0009025599,0.00022091389,0.000016683161,0.00015773285,0.000026276928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073937915,0.00056247046,0.001363378,0.0026050592,0.0001893594,0.00090238394,0.0006329296,0.0006894601,0.003642036],"category_scores_gemma":[0.0022701425,0.00020204755,0.0010555766,0.0032069387,0.00026040955,0.0007649755,0.00043307836,0.0007563405,0.0005638494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019111943,0.00005985757,0.0010307411,0.20020415,0.0008306221,0.0002933708,0.00011964306,0.00035451128,0.00061902974,0.0016563686,0.023426924,0.77121365],"study_design_scores_gemma":[0.00008755844,0.0003854262,0.010227573,0.20856988,0.0074746925,0.0047605312,0.0003223881,0.00037194614,0.0006233555,0.002724375,0.76437026,0.000082014325],"about_ca_topic_score_codex":0.0016255343,"about_ca_topic_score_gemma":0.0027770253,"teacher_disagreement_score":0.003642036,"about_ca_system_score_codex":0.0005313255,"about_ca_system_score_gemma":0.0017140736,"threshold_uncertainty_score":0.012183785},"labels":[],"label_agreement":null},{"id":"W4401521828","doi":"10.1080/17512433.2024.2390927","title":"Drug related adverse event assessment in neonates in clinical trials and clinical care","year":2024,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; KU Leuven","keywords":"Medicine; Polypharmacy; Adverse effect; Adverse drug event; Drug; Intensive care medicine; Clinical trial; Seriousness; Pharmacotherapy; Pharmacology; Internal medicine","score_opus":0.3954129327834758,"score_gpt":0.701691288093323,"score_spread":0.30627835530984726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401521828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014235689,0.99601364,0.0007871627,0.0014983029,0.00030376596,0.00011882741,0.00009206946,0.000022601744,0.0010213178],"genre_scores_gemma":[0.004691352,0.9885024,0.003272121,0.0018179839,0.000768365,0.00036556539,0.00017926385,0.00001218901,0.0003908886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9805484,0.011544682,0.0034704872,0.0008663947,0.0033603546,0.00020971154],"domain_scores_gemma":[0.9204634,0.05911823,0.012131069,0.0010432462,0.0063969237,0.0008471254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022541432,0.0010312889,0.003949693,0.0027215134,0.000271182,0.002532466,0.0017153984,0.0022185906,0.004791721],"category_scores_gemma":[0.049035553,0.0003825657,0.002346116,0.0028105231,0.00090279494,0.0018217405,0.0013154717,0.0030752996,0.0012140018],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003169443,0.000060143306,0.00070211256,0.10651701,0.0008476653,0.000121818724,0.00013317198,0.00040980958,0.00034711926,0.004068208,0.019583406,0.8668926],"study_design_scores_gemma":[0.0006084498,0.00087539764,0.007251919,0.3142208,0.0035787567,0.0024458882,0.0002729892,0.0009625022,0.0008595571,0.011911131,0.6568784,0.00013428064],"about_ca_topic_score_codex":0.0011700105,"about_ca_topic_score_gemma":0.0016899976,"teacher_disagreement_score":0.022541432,"about_ca_system_score_codex":0.0013828079,"about_ca_system_score_gemma":0.0054070614,"threshold_uncertainty_score":0.11921191},"labels":[],"label_agreement":null},{"id":"W4404727703","doi":"10.1080/17512433.2024.2433603","title":"Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pitavastatin; Rosuvastatin; Medicine; Atorvastatin; Meta-analysis; Type 2 Diabetes Mellitus; Statin; Diabetes mellitus; Internal medicine; Pharmacology; Endocrinology","score_opus":0.1150498640106041,"score_gpt":0.5001066843340876,"score_spread":0.38505682032348343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404727703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00451692,0.99363303,0.00047752858,0.0001702213,0.00014620661,0.00034888077,0.0004729865,0.000022747052,0.00021152629],"genre_scores_gemma":[0.15472737,0.838311,0.0027290303,0.0008313544,0.0003136229,0.0017786572,0.0009059173,0.000036747286,0.0003663177],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98744315,0.0054815114,0.0039796247,0.0012545305,0.0014505981,0.00039057684],"domain_scores_gemma":[0.97905207,0.015009373,0.003370669,0.0005519252,0.0017392315,0.00027678878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015765363,0.003007508,0.022661308,0.0087000765,0.0006817953,0.0039892914,0.0022725933,0.0023943947,0.0031544096],"category_scores_gemma":[0.036946643,0.0018273845,0.048989914,0.009047895,0.0006918019,0.0017129146,0.0017086448,0.0019159503,0.00028944193],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013668858,0.000022844359,0.003523704,0.3888769,0.5972739,0.00012871115,0.00007306779,0.0004729781,0.00014074009,0.00011315019,0.00042862413,0.0075785704],"study_design_scores_gemma":[0.00035127907,0.00012288624,0.002356182,0.023471866,0.9723541,0.00008465208,0.000032201257,0.00016899935,0.000072305535,0.000115271396,0.00085070566,0.000019607603],"about_ca_topic_score_codex":0.008874421,"about_ca_topic_score_gemma":0.016181724,"teacher_disagreement_score":0.022661308,"about_ca_system_score_codex":0.0034535285,"about_ca_system_score_gemma":0.004662927,"threshold_uncertainty_score":0.08337623},"labels":[],"label_agreement":null},{"id":"W4406870441","doi":"10.1080/17512433.2025.2459377","title":"The ketamine chameleon: history, pharmacology, and the contested value of experience","year":2025,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Medicine; Ketamine; Value (mathematics); Pharmacology; Clinical pharmacology; Anesthesia","score_opus":0.09890237821762422,"score_gpt":0.5332289331298158,"score_spread":0.4343265549121916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406870441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016652781,0.9611411,0.0010325126,0.022850446,0.0012335846,0.0000070556334,0.000036093763,0.000016147516,0.012017763],"genre_scores_gemma":[0.053205665,0.92996716,0.00059026416,0.010139199,0.0034853697,0.000026166785,0.000040063078,0.000020550831,0.00252557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99883574,0.0006243223,0.00008052165,0.0001739359,0.0002080456,0.00007745523],"domain_scores_gemma":[0.998298,0.0012567075,0.00014173471,0.000072826275,0.00014002254,0.000090637055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017442212,0.00041672128,0.0008084047,0.0008743515,0.0009521083,0.0034405622,0.0006978838,0.0023187094,0.0031193246],"category_scores_gemma":[0.0024565554,0.00021542048,0.00038974706,0.000920907,0.008846046,0.0043577184,0.0019633044,0.0048601427,0.000846291],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034492792,0.000046947003,0.0008029151,0.007941438,0.00009714064,0.00081000384,0.007533574,0.0003343982,0.0014923435,0.36460292,0.04327385,0.5727196],"study_design_scores_gemma":[0.00002659654,0.00017834856,0.002678434,0.00849858,0.000052305677,0.0032204227,0.0029687425,0.00018501894,0.00056312873,0.11423508,0.86732537,0.00006799071],"about_ca_topic_score_codex":0.0021170469,"about_ca_topic_score_gemma":0.0027088455,"teacher_disagreement_score":0.0034405622,"about_ca_system_score_codex":0.0022193792,"about_ca_system_score_gemma":0.0018442685,"threshold_uncertainty_score":0.01610279},"labels":[],"label_agreement":null},{"id":"W4408543281","doi":"10.1080/17512433.2025.2481868","title":"Scoping review of the availability and uptake of disease modifying therapies in children and adolescents with multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Disease; Fingolimod; Intensive care medicine; Immunology; Internal medicine","score_opus":0.10788692239457894,"score_gpt":0.4692321362050133,"score_spread":0.3613452138104344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408543281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010870297,0.9944131,0.00026885327,0.001118331,0.0002617986,0.0004469885,0.0009139429,0.000013392197,0.0014765047],"genre_scores_gemma":[0.007870087,0.9895979,0.0005480006,0.00064250355,0.00008877941,0.0005921671,0.0004226368,0.000008000456,0.00022985216],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9874155,0.0036561363,0.005462665,0.00079257373,0.0023788519,0.0002942664],"domain_scores_gemma":[0.93264747,0.050225142,0.009822544,0.0009142826,0.005954172,0.0004363822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015416675,0.0011473371,0.004425003,0.0133032985,0.0008916759,0.0035014711,0.0017894419,0.0022189717,0.0073833545],"category_scores_gemma":[0.074971214,0.0009591769,0.0048989346,0.01477729,0.0010990854,0.0024906974,0.0019406732,0.0014412339,0.0008184353],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009874851,0.000019488363,0.0012826431,0.892614,0.0028245852,0.00014157542,0.0005649308,0.00013171436,0.00017816397,0.0006659251,0.005631804,0.09584638],"study_design_scores_gemma":[0.000025030819,0.000030446745,0.0019077325,0.96422434,0.0065100715,0.0001649976,0.00021851879,0.000027313301,0.00008198504,0.0001798819,0.026620068,0.000009698318],"about_ca_topic_score_codex":0.012338772,"about_ca_topic_score_gemma":0.024822842,"teacher_disagreement_score":0.015416675,"about_ca_system_score_codex":0.0038069622,"about_ca_system_score_gemma":0.017630393,"threshold_uncertainty_score":0.08153218},"labels":[],"label_agreement":null},{"id":"W4415551402","doi":"10.1080/17512433.2025.2580349","title":"A review of current and emerging therapies in breast cancer: implications for older adults","year":2025,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Clinical trial; Breast cancer; Geriatric oncology; Alternative medicine; MEDLINE; Disease","score_opus":0.1191470631710012,"score_gpt":0.599206417123631,"score_spread":0.4800593539526298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415551402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048762988,0.99892044,0.000050741422,0.0003835078,0.00017510692,0.000004759414,0.000017628543,0.0000036839822,0.00039538008],"genre_scores_gemma":[0.00032171933,0.99890673,0.000093661016,0.00031092516,0.00014177787,0.0000056823096,0.000017527067,6.9365e-7,0.00020118286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965334,0.00008301939,0.000070688024,0.0000523134,0.0001138541,0.000026909867],"domain_scores_gemma":[0.9991198,0.00052182045,0.000119261436,0.000014243502,0.0001842444,0.000040686788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083296,0.00070135517,0.0012317161,0.0022711386,0.00028765213,0.0009357945,0.0007262051,0.0010565071,0.0050380924],"category_scores_gemma":[0.0016599497,0.0002332497,0.0012053485,0.0018854521,0.000298633,0.0011122301,0.0005213117,0.0018399679,0.0013460892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009302575,0.0000606066,0.00016070527,0.060401794,0.00018880548,0.00013227263,0.00007885316,0.00029789357,0.00070893165,0.002546658,0.050123964,0.8852065],"study_design_scores_gemma":[0.000036651305,0.00014482178,0.0010687103,0.033609677,0.00047946564,0.0010768798,0.00007506831,0.00012315341,0.00019091899,0.001894514,0.96127826,0.000021880904],"about_ca_topic_score_codex":0.0012529811,"about_ca_topic_score_gemma":0.0031032516,"teacher_disagreement_score":0.0050380924,"about_ca_system_score_codex":0.0006608649,"about_ca_system_score_gemma":0.001563365,"threshold_uncertainty_score":0.016854048},"labels":[],"label_agreement":null},{"id":"W4415803870","doi":"10.1080/17512433.2025.2585448","title":"Drug-drug interactions in anticoagulant therapy: a focus on oncology patients","year":2025,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Context (archaeology); Pharmacy; Anticoagulant; Venous thromboembolism; Dabigatran; Focus (optics); Cancer; Anticoagulant therapy","score_opus":0.07158266839678182,"score_gpt":0.5203596241519342,"score_spread":0.4487769557551523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415803870","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019289006,0.98622966,0.00026286187,0.008878389,0.0004597409,0.000010984598,0.00006747111,0.0000060310426,0.0021560225],"genre_scores_gemma":[0.019558415,0.9725883,0.00050354836,0.0049661137,0.001641619,0.00001622731,0.0000837565,0.0000036839226,0.0006382788],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99913895,0.00033729922,0.00012720353,0.00012509774,0.00021871492,0.000052777246],"domain_scores_gemma":[0.9964617,0.0021480627,0.0006909403,0.000033021002,0.0005160041,0.00015028637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009909166,0.0003655848,0.00081053906,0.00113169,0.00028681278,0.0010927905,0.0003197747,0.0010818864,0.0054089366],"category_scores_gemma":[0.003522836,0.000094272196,0.000534661,0.0016483284,0.0003492894,0.0012957823,0.00064109766,0.0012251881,0.0004972239],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017977554,0.00008542135,0.008176589,0.039939683,0.0002852257,0.0011731976,0.00078400614,0.00026824797,0.00091375684,0.0042883405,0.059368312,0.8845375],"study_design_scores_gemma":[0.00005973494,0.0003351915,0.048365563,0.07592183,0.0009712073,0.019647062,0.0025004353,0.00034744517,0.00051774294,0.0062864264,0.8449758,0.00007158704],"about_ca_topic_score_codex":0.0014244899,"about_ca_topic_score_gemma":0.0032551931,"teacher_disagreement_score":0.0054089366,"about_ca_system_score_codex":0.0006006411,"about_ca_system_score_gemma":0.0015107378,"threshold_uncertainty_score":0.018094718},"labels":[],"label_agreement":null},{"id":"W4415833725","doi":"10.1080/17512433.2025.2585449","title":"A comprehensive systematic review of the types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class","year":2025,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deprescribing; Class (philosophy); Drug class; Polypharmacy; Alternative medicine; MEDLINE","score_opus":0.29893373787402444,"score_gpt":0.5729955539405893,"score_spread":0.2740618160665649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415833725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017863305,0.9950321,0.00033974103,0.00028535465,0.00013038125,0.0007421023,0.0011727975,0.000014643027,0.0004965838],"genre_scores_gemma":[0.015701987,0.98005944,0.0013636524,0.0005260365,0.00007062616,0.0014965427,0.00057576236,0.000008421702,0.0001975052],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895789,0.0031441024,0.0044053984,0.00077503844,0.0018249622,0.00027165795],"domain_scores_gemma":[0.9766286,0.016235555,0.0042996965,0.00034801627,0.0022382266,0.0002498855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0088483,0.0018627607,0.008212174,0.012266658,0.0008464431,0.0025638968,0.001985854,0.0017418832,0.005306665],"category_scores_gemma":[0.036283493,0.0010392076,0.0070194826,0.014309839,0.00091646344,0.002543355,0.0015585887,0.0009447987,0.00043096812],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011337002,0.000008994753,0.00041589807,0.97411555,0.004372324,0.000067897614,0.00013985693,0.000063647305,0.00013436447,0.00013854864,0.0010071764,0.01942242],"study_design_scores_gemma":[0.00022266847,0.00016453418,0.0031684493,0.91662985,0.0624386,0.00026643093,0.00023039979,0.000079503996,0.0002218795,0.00021835898,0.016330114,0.00002914075],"about_ca_topic_score_codex":0.00944851,"about_ca_topic_score_gemma":0.027348319,"teacher_disagreement_score":0.012266658,"about_ca_system_score_codex":0.004499947,"about_ca_system_score_gemma":0.017640488,"threshold_uncertainty_score":0.04679483},"labels":[],"label_agreement":null},{"id":"W4416742622","doi":"10.1080/17512433.2025.2596875","title":"Progress in the pharmacological management of vasovagal syncope","year":2025,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Vasovagal syncope; SAFER; Adverse effect; Clinical pharmacology; Blood pressure; MEDLINE","score_opus":0.04798331342320885,"score_gpt":0.498522488480167,"score_spread":0.4505391750569582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416742622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052222086,0.9887761,0.00040050125,0.0062345946,0.00070101104,0.000010834684,0.000029511722,0.000017931921,0.003307321],"genre_scores_gemma":[0.005866143,0.98690957,0.0011335294,0.0031137548,0.0019004581,0.000019631761,0.00006194773,0.000008366151,0.0009865476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999388,0.00015602066,0.00008188721,0.00011099051,0.000207891,0.00005529923],"domain_scores_gemma":[0.99805707,0.0010510327,0.00024867718,0.00004518907,0.0005003604,0.000097718395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017418755,0.00050393614,0.0009293889,0.0008626609,0.00025717117,0.0013124795,0.0007097448,0.0012463933,0.00488829],"category_scores_gemma":[0.0026249243,0.00017215559,0.00075641304,0.0005364275,0.00043901877,0.0013223522,0.0005675948,0.0032624947,0.0020200643],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014891097,0.00011488143,0.00044508508,0.0065800613,0.000088338136,0.0001450333,0.00007537982,0.00024320609,0.00078476145,0.0033043441,0.026222885,0.96184707],"study_design_scores_gemma":[0.00016760646,0.0005806256,0.004277557,0.017602218,0.00032592425,0.0027586962,0.0002320074,0.0004940134,0.0006756309,0.006148282,0.9666972,0.000040221712],"about_ca_topic_score_codex":0.0011014568,"about_ca_topic_score_gemma":0.0017958609,"teacher_disagreement_score":0.00488829,"about_ca_system_score_codex":0.0007040661,"about_ca_system_score_gemma":0.0011437857,"threshold_uncertainty_score":0.016352952},"labels":[],"label_agreement":null},{"id":"W7117151818","doi":"10.1080/17512433.2025.2609659","title":"Shaping future deprescribing priorities: outcomes of a World Café stakeholder workshop","year":2025,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; University of British Columbia","funders":"","keywords":"Deprescribing; Stakeholder engagement; Stakeholder; Workforce; Bridge (graph theory); Enabling; Polypharmacy","score_opus":0.7589525289218272,"score_gpt":0.7529174369504285,"score_spread":0.006035091971398732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117151818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89157045,0.0016282678,0.0052943015,0.067463405,0.0009992797,0.0031469094,0.00062744226,0.00012369613,0.029146384],"genre_scores_gemma":[0.9625828,0.0018026063,0.008574641,0.014554081,0.00023226567,0.002808219,0.00032693602,0.00014110551,0.008977419],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.96496403,0.028382823,0.0007822147,0.0008996541,0.0018167135,0.0031545358],"domain_scores_gemma":[0.9109419,0.05284623,0.0042929994,0.002742917,0.011740062,0.017435873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07364347,0.00064406457,0.00073005276,0.0012997839,0.012870495,0.007553072,0.0022729165,0.0049285237,0.0059948266],"category_scores_gemma":[0.07016961,0.00059136475,0.0010071938,0.0010105815,0.0042491546,0.0055449926,0.016516546,0.005708505,0.0010705267],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006896876,0.0029364643,0.016417315,0.002390803,0.00011815501,0.0029711365,0.80751824,0.0004346401,0.0018446245,0.0070952196,0.04028624,0.11729741],"study_design_scores_gemma":[0.00020011309,0.0010778344,0.016257735,0.0016998871,0.00007405584,0.00033171818,0.8491995,0.0005270393,0.0012262143,0.0030539515,0.12619162,0.00016037424],"about_ca_topic_score_codex":0.0067265434,"about_ca_topic_score_gemma":0.0136518,"teacher_disagreement_score":0.07364347,"about_ca_system_score_codex":0.0086489115,"about_ca_system_score_gemma":0.021523265,"threshold_uncertainty_score":0.38946855},"labels":[],"label_agreement":null}]}